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Abstract 
 
In the central nervous system ATP can be released by neurons and glial cells through 
similar pathways as other neurotransmitters. Extracellular ATP targets P2X purinoreceptors, 
causing an influx of Ca
2+ 
ions which transmit very important messages for neurons and glial 
cells.  Ionic signals modulated by P2X receptors can be transformed into the modulation of 
GABAA receptors.  This work describes the universal interaction of P2X receptors down-
regulating GABAA mediated currents via a Ca
2+
-dependent mechanism. 
 I have shown that the postsynaptic modulation of GABA currents by P2X receptors is 
present in both the peripheral (DRG neurons) and central nervous system (cortical neurons).  
This effect is strongly regulated by an intracellular signalling cascade involving Protein Kinase 
C.  Furthermore, tonically-activated GABAA receptors expressed on central neurons, containing 
alpha5 and delta subunits are also affected by this P2X and GABAA receptor interaction.    
The purinergic modulation of GABAA receptors has significant implications for synaptic 
plasticity, an important mechanism of learning and memory in the central nervous system.  The 
down-regulation of GABAA receptors on the postsynaptic membrane enhances the activity of 
NMDA receptors and thus increases synaptic efficacy.  The study of the purinergic involvement 
in the induction of Long Term Potention is far from being understood.  Ionotrophic 
purinoceptors represent a novel pathway of GABAA receptor modulation: release of ATP from 
neurons and astrocytes activates Ca
2+
- signalling via purinergic P2X receptors, which can 
regulate GABAA receptors activity in both peripheral and central nervous system compartments. 
The physiological implications of this regulatory pathway are yet to be investigated. 
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Chapter 1 
Introduction 
  
 For decades the nucleotide adenosine triphosphate (ATP) was merely considered a form of 
molecular currency for the transfer of energy between cells (Knowles, 1980).  However, in 1972, 
experimental analysis revealed the potential of ATP to function as a neurotransmitter (Burnstock, 
1972).  This new extracellular role for an intracellular entity was widely disputed; engendering a 
flurry of research there-on-after.  Now, there is a plethora of strong evidence indicative of the 
extracellular signalling properties of ATP, leading to the discovery of the purinergic receptors.    
 The role of extracellular ATP in fast excitatory synaptic transmission in the peripheral 
nervous system is well established (Silinksy et al., 1992).   However, data from the last decade 
has demonstrated that ATP can also mediate fast excitatory transmission in the central nervous 
system (Jahr and Jessell, 1983; Edwards et al., 1992).  Extracellular ATP can be released 
vesicularly from central neurons at both inhibitory and excitatory nerve terminals alone or along 
with GABA and glutamate (Burnstock, 2009).  The precise demonstration of the fast excitatory 
purinergic transmission has been reported in many brain regions including, the spinal cord, 
hippocampus and the neocortex (Sawynok et al., 1993; Salgado et al., 1996;  Pankratov et al., 
2003b) where the action of extracellular ATP is mediated by the ionotrophic P2X receptor 
family. 
 Multiple purinergic receptors have been found to be expressed on another type of brain cell 
called glial cells.  Despite being referred to as “brain glue,” non-excitable cells which are 
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responsible for maintaining the surrounding environment of neurons, glial cells can also 
vesicularly release ATP, via a mechanism termed gliotransmission.  Consequently, many 
important neuron-glial cell communications in the central nervous system have been described, 
introducing the concept of the tripartite synapse.     
  The high permeability of purinergic receptors to calcium at low membrane potentials 
creates a strong calcium dependence on the regulatory actions of extracellular ATP.  P2X 
receptors ability to transmit robust calcium signals is a principal property which allows them to 
modulate the activity of other receptors and thus synaptic transmission.  Intracellular calcium 
levels can affect the function of a plethora of membrane proteins including GABA receptors.  To 
date research which focuses on the direct influence of ATP on inhibitory nerve terminals in the 
tripartite synapse is extremely limited, hence this current body of work concentrates on this 
aspect of purinergic signalling and predominantly focuses on GABA homeostasis in the central 
nervous system.  
1.0 Physiology of purinergic receptors 
 One of the primary functions of extracellular ATP is to act as a ligand to activate the P2 
purinergic receptors, which are non-selective cation channels permeable to Na
+
, K
+
 and Ca
2+ 
ions 
(Ralevic and Burnstock, 1998).  The secondary effects of purinergic neuromodulation are 
governed by the rapid breakdown of ATP in the synaptic cleft by resident ectonucleotidases.  
One of the breakdown products of ATP, adenosine diphosphate (ADP), can activate some P2 
receptor subtypes.  Another  compound produced via the breakdown of ATP is adenosine, which 
acts as a ligand to the P1 receptors, a subclass of purinoreceptors that are expressed on all 
neuronal cells (North and Verkhratsky, 2006).  The properties of adenosine in neurotransmission 
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are well studied, however due to its rapid degradation upon release; research exploring the 
effects of ATP on postsynaptic receptors still remains rather fragmented.   
 The P2 receptor family are further sub-categorised into the ionotrophic P2X receptors and 
the metabotropic P2Y receptors, distinctly coupled to G-proteins (Abbracchio and Burnstock, 
1994; Illes and Ribeiro, 2004).  Multiple purinergic receptors have been found to be expressed 
on another type of brain cell called glial cells, which can also release ATP via a process called 
gliotransmission.  Consequently, important purinergic mechanisms involving neuron and glial 
cell interactions have been described in recent years (James and Butt, 2002; Lalo et al., 2008; 
Palygin et al., 2010; Koles et al., 2011).   
 It is acknowledged that the P2X receptors are comprised of seven different receptor 
isoforms, namely P2X1 to P2X7, which are widely distributed in both the peripheral and central 
nervous systems.  Each subunit measures approximately between 379 and 595 amino acids in 
length (Khakh et al., 2001).  The P2X receptor subunits exhibit both homomeric and heteromeric 
stoichiometry, evoking a wide range of kinetically distinct receptor functions.  Torres et al. 
(1999) suggested the existence of several hetero-oligomers for P2X receptors: subunits 1/5, 1/6, 
2/3, 2/5, 2/6, 3/5, 4/5, 4/6, 5/6.  Research has demonstrated that P2X receptors assemble with a 
general ratio of at least three monomers to one functional receptor (North and Verkhratsky, 
2006).  For example, previous data has demonstrated that the molecular assembly of receptor 
subunits P2X1 and P2X3 consists of stable trimers on the cell membrane (Nicke, 1998).  
Additionally, it is established that P2X2 to P2X5 can form stable and functional homomeric 
receptors (Torres et al., 1999).  Immunohistochemical studies and dark-field photomicrographs 
have documented the abundant distribution of P2X2 and P2X3 mRNA in adult DRG neurons 
(Vulchanova et al., 1997). The protein subunits may assemble as homomeric or heteromeric 
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receptors (P2X2/3) (Grubb and Evans, 1999).  However, in the central nervous system the most 
predominant functional P2X receptor expressed on neurons is P2X4 (Norenberg and Illes, 2000; 
Lalo et al., 2007). 
 The characterisation of the currents elicited by the different subunit combinations of P2X 
receptors on DRG neurons have suggested the presence of “fast,” “slow” and “mixed” type 
currents (Grubb and Evans, 1999; Sokolova et al., 2001).  A comparison of the pharmacological 
profiles of the different receptor subunits combined with the tissue distribution patterns of P2X 
receptor mRNA, can determine which specific P2X receptor subtype corresponds to a particular 
characteristic response.  The variety of P2X subunit combinations can yield a range of P2X 
receptor characteristics, including kinetically distinct phenotypes and various biophysical 
properties such as different sensitivities to receptor agonists and antagonists between the 
purinergic receptor subtypes.  Therefore, the distinctive nature of the variety of P2X receptors 
expressed in the peripheral and central nervous systems provides a significant platform for a 
wide range of ATP signalling with a dynamic array of modulatory functions.   
 In contrast to the ionotrophic P2X receptors the metabotropic P2Y receptors are G-Protein 
coupled receptors, composed of the hallmark seven transmembrane domains.  To date, ten 
subtypes have been identified and functionally defined (Abbracchio et al., 2003; Illes and 
Ribeiro, 2004) with the receptor binding sites residing on the sixth and seventh transmembrane 
domains (Burnstock, 1997).   The receptor subtypes localised in the central nervous system 
include P2Y1, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14 (Moore et al., 2001).  Despite the 
possible roles of P2Y receptors in neuromodulation and synaptic integration our research group 
is currently interested in the impact of P2X receptors on synaptic transmission in the central 
nervous system. 
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Figure 1.0:1. A summary of the molecular, pharmacological and physiological properties of 
P2X receptors in the central nervous system. Table adapted from Jarvis and Khakh 2009. 
 
 
 
 
 
 P2X1 P2X2 P2X3 P2X4 P2X5 P2X6 P2X7 
Molecular Properties        
Membrane Expression Good Good Good Good  Poor No 
expression  
Good 
Dessensitisation
1
 < 1 s > 20 s < 1 s > 20 s > 20 s N/A > 20 s 
Pore Dilation No Yes No Yes N/A N/A Yes 
PCa/P4Na 4.8 2.8 1.2 4.2 1.5 N/A N/A 
Fractional Ca2+ Conductance 
(%)
3
 
12.4 5.7 2.7 11 4.5 N/A 4.6 
        
Pharmacology        
Agonist EC50 values (µM)         
ATP 0.07 1.2 0.5 10 10 12 100 
2meSATP 0.007 1.2 0.3 10 10 9 100 
α,β-meATP 0.3 >300 0.8 >300 >300 >100 >300 
BzATP 0.003 0.75 0.08 7 >500  20 
Antagonist EC50 values (µM)       
Suramin 1 10 3 >500 4 >100 500 
PPADS 1 1 1 >500 3 >100 50 
TNP-ATP 0.006 1 0.001 15 N/A N/A >30 
KN-62 N/A N/A N/A N/A N/A N/A 0.3 
RO-3 >10 >100 0.1 >100 >100 N/A >100 
NF279 9 30 50 >100 N/A N/A 20 
NF449 0.7 >100 >100 >100 N/A N/A >100 
        
Physiology and Pathophysiology       
Major cellular expression Smooth muscle Neurons Pain-sensing 
neurons 
Microglia Skeletal 
muscle 
Broad 
Expression 
Immune cells 
 
Major role 
 
Neuroeffector     
transmission 
 
Taste, pre- 
and post-                                        
synaptic 
responses 
 
Bladder 
reflexes,              
chronic pain, 
taste 
 
Vascular 
remodelling,                 
neuropathic 
pain 
 
N/A 
 
N/A 
 
Bone 
reabsorption,                                 
chronic pain 
        
  
15 
 
1.1 ATP release from neurons and astrocytes in the central nervous systems 
  Due to the size of ATP molecules they are unable to simply diffuse across the plasma 
membrane (Chaudry, 1982), suggesting more specialised pathways are required for ATP release.  
A variety of release mechanisms can operate in the peripheral nervous system and in the CNS, 
exocytotosis being the prime release method.  Previously, compelling evidence has been reported 
in support of the neuronal vesicular release of ATP in the neocortex (Pankratov et al., 2007).  
ATP is accrued and stored in synaptic vesicles, alone (Pankratov et al., 2007) or with other 
neurotransmitters, such as inhibitory GABA and excitatory glutamate (Mori et al., 2001; Jo and 
Role, 2002).  The co-release of ATP occurs frequently at nerve terminals in the brain.  Calcium 
dependent release of ATP was first recognised in 1977 by a group working on whole cell 
synaptosomes (White, 1977).  Since this revolutionary study an abundance of research in support 
of the vesicular release of ATP has been published (Jo and Role, 2002; Pankratov et al., 2006; 
Lazaroski, 2012).   
  Understanding the mechanisms underlying the storage and release of ATP remain 
fragmented.  It is not entirely sure whether exocytosis is wholly responsible for ATP secretion in 
the central nervous system, evidently there is much data to suggest otherwise (Wang et al., 2000; 
Halassa et al., 2009).  Hence, other feasible non-vesicular approaches have been advocated, such 
as gap junction hemichannels and ATP binding cassettes (North and Verkhratsky, 2006).   
The potential of astrocytes to release ATP by utilising similar methods employed by 
neurons has recently been revealed (Illes and Ribeiro, 2004) and studied in cultured expression 
systems (Queiroz et al., 1997; Jeremic et al., 2001).  One study supports the hypothesis of ATP 
release from astrocytes by exocytosis, which may involve lysosomes (Zhang et al., 2003).  As 
well as ATP, astrocytes are able to release many other gliotransmitters such as D-serine and 
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glutamate.  The release of glutamate from astrocytes has many features which resembles synaptic 
vesicular release, as it is also dependent on the SNARE proteins (soluble N-ethylmaleimid 
sensitive factor attachment protein receptor) (Araque et al., 2000), a formation of a multi-
complex of vesicular and membrane proteins (Halassa et al., 2009) and an elevation in the 
intracellular calcium concentration (Malarkey and Parpura, 2008).  ATP release was also 
inhibited in mice which expressed a genetically modified dominant-negative SNARE complex 
(Pascual et al., 2005).  The expression of the core machinery in glial cells required for vesicular 
release reinforces the idea of exocytotic release of ATP from astrocytes.  Furthermore, vesicle 
imaging studies have associated the secretion of ATP from astrocytes evoking glial cell derived 
calcium waves (Pangrsic et al., 2007; Bowser and Khakh. 2007a; Bowser and Khakh, 2007b).   
Most of the studies on the exocytotic release of ATP from astrocytes have been 
conducted in vitro on cultured cells, which have raised many questions about the functional 
significance of this neurotransmitter release method in vivo (Hamilton and Attwell, 2010).  
However, vesicular release of ATP from acutely isolated cortical astrocytes has been 
demonstrated in recent years (Pankratov el al., 2006), highlighting the physiological relevance of 
this ATP release mechanism from astrocytes.   
 A role for gap-junction hemichannels that assemble in astrocytes as hexamers of connexion 
43 (Volterra and Meldolesi, 2005) has also been implicated as a mechanism for the astroglial 
release of ATP.  However, the opening probability of hemichannels inside astrocytes is very low, 
but is increased marginally by reducing the intracellular Ca
2+
 concentration.  This results in the 
release of glutamate and ATP from astroglia (Stout et al., 2002; Ye et al., 2003).  Inhibition of 
the release of gliotransmitters is caused by the implementation of gap junction blockers, 
emphasising the role of hemichannels in astroglial ATP release (Volterra and Meldolesi, 2005).  
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Additionally, ATP binding cassettes (e.g. multi-drug resistance protein) have been implicated to 
evoke the release of ATP from astrocytes (Ballerini et al., 2002).  Moreover, Darby et al. (2003), 
postulated that on binding to P2Y receptors, ATP activates swelling-induced chloride currents 
(ICl, swell).  This in turn releases ATP from the astrocytes (Darby et al., 2003).  Hence, current 
evidence indicates that ATP secretion may occur through channels and transporters as well as via 
synaptic vesicles, but numerous aspects of these potential release pathways are yet to be 
explained.  
1.2 P2X receptors and the importance of calcium signalling 
  Typically the amplitude of an ATP current evoked from activated P2X receptors 
expressed on central neurons ranges from 50-100 pA (Pankratov et al., 2008).  Purinergic 
receptors are widely expressed in the central nervous system and despite the small amplitude of 
their response they represent an important modulatory pathway of synaptic function especially in 
consideration of their calcium signalling capabilities on both neurons and glial cells.   All P2X 
receptors are permeable to calcium ions and the ratio of calcium permeability to other cations 
such as Na
+
 and K
+
 ranges between 1 to 10, depending on the P2X subunits present (Egan et al., 
2006; Abbracchio et al., 2009).  P2X receptors expressed in the somatosensory cortex have an 
extremely high permeability to calcium which is similar to the permeability of NMDA receptors 
to calcium (Abbracchio et al., 2009).  Therefore, P2X receptors in the central nervous system 
represent an important source of calcium influx into the postsynaptic cell at resting membrane 
potentials when synaptic NMDA receptor channels are blocked by Mg
2+
 (Pankratov et al., 
2003a). 
 A population of highly Ca
2+ 
permeable P2X and P2Y receptors are expressed on astrocytes.  
The binding of ATP or its analogues evokes a conformational change within the P2X receptor, 
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which allows the passage of cations such as Ca
2+
.  The transient increase in the intracellular Ca
2+ 
concentration can produce long-term changes, for example, cell proliferation and apoptosis  
(Neary et al., 1996; Ciccarelli et al., 2001).  Bennett et al. (2005), describe the sustained response 
of calcium signalling in astrocytes after the application of ATP.  As such, they discovered that 
this response was due to the perpetual influx of  Ca
2+
 ions through P2X7, and is  mediated by  
P2Y1 and P2Y2  receptors (Bennett et al., 2005). 
  An important property of  P2X receptors is their ability to transmit robust Ca
2+
 signals 
even at resting membrane potentials (North, 2002), unlike NMDA receptors which require 
depolarisation to remove the Mg
2+
 ion block (Pankratov et al., 2003a).  The ratio of neuronal 
P2X receptors permeability to calcium ions over other monovalent cations such as Na
+
 and K
+
 
ranges from 2 to 12 (Pankratov et al., 2009).  Similar results were obtained when testing for the 
permeability of NMDA glutamate receptors to calcium ions.  Therefore, functional P2X 
receptors represent an important source of calcium influx to postsynaptic neuronal cells at low 
membrane potentials.   
 Calcium signalling in the CNS is crucial for neurotransmission and recent emphasis has 
been applied to its physiological role in purinergic mediated transmission on neurons and glial 
cells in the central nervous system (James and Butt, 2002).  The receptors permeation to cations 
may be attributed to structural components, TM1 and TM2.  The permeation capability of the 
channel pore is principally assigned to TM2, which also regulates conductance and Ca
2+
 influx 
into the cell (Egan et al., 2006).  The role of TM1 in monovalent cation permeability has yet to 
be defined (Samways et al., 2008).  The increase in intracellular Ca
2+
 levels is governed by P2X 
receptors via two specific mechanisms.  Firstly, their ability to mediate a depolarizing current 
results in the opening of voltage-dependent Ca
2+
 channels.  Secondly, P2X receptors are 
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permeable to Ca
2+
 subsequent to receptor activation by ATP producing a vast Ca
2+
 influx.  Many 
research groups have measured the Ca
2+
 permeability’s of P2X receptors – in most cases the 
permeability was close to more profuse cations present in the extracellular space, such as Na
+
 
ions (Egan et al., 2006).   
 Cytosolic calcium plays a fundamental role for non-excitable cells in inter- and 
intracellular communications (Braet et al., 2004).  Bennett et al. (2005) postulate that inositol-
1,4,5-triphosphate (IP3) plays a central role to the junctional transmission of Ca
2+
 between 
astrocytes, initiated by a G-protein cascade on the activation of P2Y receptors.  The groups 
model is based on IP3 proceeding to diffuse through gap junctions to act on the internal Ca
2+ 
stores, residing within the endoplasmic reticulum.  Consequently, Ca
2+ 
is released into the 
cytosol and
 
activates phospholipase C to create more IP3.  This cycle is regenerative as the IP3 
produced diffuses and acts on neighbouring cells.  Furthermore, scraping away astrocytes does 
not prevent Ca
2+
 signals propagating from one astrocyte to the other (Hassinger et al, 1996).  
Hence, this data suggests that astrocytes perhaps release a chemical transmitter alongside the 
diffusible Ca
2+ 
signal.  Imaging of ATP and Ca
2+ 
were documented after experimental 
stimulation of an astrocyte (Wang et al., 2000).     
Recently, the extent of the contribution of astroglial derived calcium signalling via P2Y 
activation has been disputed.  Studies have revealed that a reduced or elevated level of P2Y-
mediated calcium signalling failed to have an effect on synaptic transmission, in the 
hippocampus of mice with a genetically modified IP3 calcium activation pathway (Petravicz et 
al., 2008; Agulhon et al., 2010).  However, the primary focus of this current study is the role of 
the ionotrophic P2X purinoreceptors in the bi-directional signalling between neuron and glial 
cells, which has largely been ignored.   
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 Accumulating evidence has suggested that ATP arbitrates Ca
2+
 transmission, thus 
increasing the levels of cytosolic calcium in glial cells and neurons.  Neuronal stimulation is able 
to induce Ca
2+
 signalling in astrocytes, which in turn is able to propagate back to neuronal 
synapses to modulate synaptic transmission.  This neuron-glial cell signalling pathway highlights 
the potential of purinergic driven regulation of synaptic transmission and brain function mediated 
by Ca
2+
 ion conductance.   
1.3 The role of glial cells in neurotransmission and the concept of the tripartite synapse 
 Although neurons are an essential component for the general functioning of the nervous 
system, studies have previously highlighted the importance of another type of brain cell called 
glial cells in synaptic transmission.  Glial cells are non-neuronal cells residing within the nervous 
system, providing nutrition and support and maintaining homeostasis.  They are widely dispersed 
in both the central and peripheral nervous systems.  Amongst the glia in the CNS, the specialised 
functions of oligodendrocytes and microglia have long been established: axon myelination and 
immune defence in the CNS, respectively.  However, the role of astrocytes has proven to be 
much more elusive.   
  Initially it was perceived that astroglia simply operated as “brain glue,” essential for the 
distribution and interaction of neurons (Volterra and Meldolesi, 2005).  Later studies have 
demonstrated that astrocytes express ion channels and receptors which are involved in 
neurotransmission (Volterra and Meldolesi, 2005), thus assigning a possible role to astrocytes as 
a component of neuronal signalling.  Nevertheless, new insights suggest precise roles have been 
assigned to astroglial cells including, vasomodulation, regulation of synapse formation and 
facilitating myelination (Parri and Crunelli, 2003; Volterra and Meldolesi, 2005; Ishibashi et al., 
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2006).  The slow pace of these discoveries emphasises that many aspects of the principal 
functions of astrocytes are yet to be clarified.   
  Our static notions about astroglial cells perhaps derive from their inability to generate 
action potentials and therefore were deemed unexcitable.  Upon finding that astrocytes can in 
fact be stimulated non-electrically our knowledge of the communication systems in the brain has 
been extended immensely (Volterra and Meldolesi, 2005).  Glial cells play a dynamic role in 
neurotransmission as they are endowed with a generous number of receptors; permitting them to 
identify neuronal activity (North and Verkhratsky, 2006).  All glial cells are highly sensitive to 
ATP as they abundantly express purinergic ATP receptors and accumulating evidence suggests 
that astroglial ATP may arbitrate Ca
2+
 transmission in the central nervous system (Kirischuk et 
al., 1995; Hassinger et al., 1996; Cotrina et al., 2000; Fields and Stevens, 2000; Verkhratsky and 
Steinhäuser, 2000; Wang et al., 2000).  ATP release from astrocytes can also be generated by the 
P2Y receptors, mediating propagating Ca
2+
 waves via the actions on inositol-1,4,5-triphosphate 
(IP3) (Verkhratsky and Steinhäuser, 2000; Bennett et al., 2005).  The role of the P2X1-6 receptor 
subunits in astroglial processes remains enigmatic, however currents governed by P2X receptors 
in astrocytes have been reported in culture (Walz et al., 1994) and have been described recently 
in cortical astrocytes in situ (Lalo et al., 2008).   
 In the CNS astroglial cells are intimately associated with synaptic junctions where they 
help to maintain the integrity of the extracellular environment (Fields and Stevens, 2000).  ATP 
can function as a powerful signalling molecule between neurons and glial cells as illustrated by 
experimental analysis of Schwann cells at synaptic and non-synaptic regions (Robitaille. 1995; 
Stevens and Fields, 2000).  Therefore, the abundance of purinergic release mechanisms and the 
extensive distribution of purinergic receptors in the CNS suggest that ATP could mediate 
  
22 
 
communication between cells on a much larger scale.  This hypothesis associates ATP’s neuron-
glial signalling potential with many dynamic functions outside maintaining the extracellular 
environment of surrounding neurons.   
 P2X receptors expressed on astroglial cells are activated by the diffusion of 
neurotransmitter released from the presynaptic membrane for synaptic transmission, arbitrating 
fast localised signalling as a result of enhanced intracellular calcium concentrations (Lalo et al., 
2011).   The ensuing ionic signals produced can be transformed into a plethora of physiological 
responses, including activation of intracellular signalling cascades, initiating the release of 
gliotransmitters, neuronal homeostasis and the calcium dependent modulation of receptors 
located on the postsynaptic membrane such as NMDA and GABA receptors.  For instance, 
highly sensitive astroglial purinoreceptor subtype P2X1/5 (EC50 50 nM) are able to recognise 
small changes in the concentration of extracellular ATP in the synaptic cleft and therefore able to 
detect neuronal activity.  This suggests that astroglial P2X1/5 receptors may alter the neuronal 
support provided by astrocytes accordingly (Lalo et al., 2011).  Thus, the activation of 
ionotrophic P2X receptors represent an innovative mechanism for the modulation of synaptic 
transmission mediated by glial cells, which involves the release of ATP from neurons and 
astrocytes in the central nervous system.  
The role of neuron-glial communication is currently not fully understood (Fields and 
Stevens, 2000), however it is established that it allows the bi-directional interaction between 
neurons and glial cells (Volterra and Meldolesi, 2005).  The release of ATP from astroglial cells 
makes them a major source of adenosine, a metabolite of the degradation of ATP in the synaptic 
cleft which can inhibit synaptic transmission upon the activation of neuronal P1 receptors.  Thus, 
emphasising the significant role of astroglial derived purinergic transmission in modulating 
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synaptic signalling in the CNS.  Although the modulatory role of adenosine in the brain is well 
studied a considerable amount of work is still required to ascertain the specific role of neuron 
and glial cell derived ATP on brain function.  Understanding the purpose of this specialised 
tripartite complex (Fig.1.3:2) and its impact in controlling neuronal excitability and 
neurotransmission is perhaps vital in comprehending the pathophysiology of many neurological 
and psychiatric disorders.  
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Figure 1.3:2. A schematic diagram of the tripartite synapse 
Astroglial cells express many of the same receptors as neurons in the central nervous system.  
Upon the release of neurotransmitters from the presynaptic terminal, receptors expressed on 
astrocytes are also thought to be activated by the diffusion of neurotransmitter in the synaptic 
cleft.  This causes oscillations in the intracellular calcium levels in the astrocytes which can then 
propagate to neighbouring astrocytes.  The rise in intracellular calcium leads to the release of 
gliotransmitters such as ATP, glutamate and D-serine.  These gliotransmitters act on the 
postsynaptic membrane to modulate synaptic transmission.  
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1.4 Roles for P2X receptors in the modulation of synaptic transmission and plasticity 
1.4.1 Modulation of neurotransmitter release by presynaptic P2X receptors 
  There are a multitude of different receptors widely expressed on the presynaptic nerve 
terminal in the central nervous system, which include the ionotrophic P2X and metabotropic P2Y 
receptors (Illes and Ribeiro, 2004).  Purinergic receptors operate as regulatory “hotspots” for 
ATP release and other neurotransmitters, ensuing neuronal stimulation of postsynaptic cells and 
cell signalling.  The local positioning of these receptors permits efficient and controlled 
transmitter release accordingly.  Moreover, this appropriate positioning of the highly Ca
2+
 
permeable purinergic receptors emphasises their modulatory role, as they could directly yield 
transmitter release initiated by the Ca
2+
 influx through the receptors ion channel (MacDermott et 
al., 1999).   
 The modulation of neurotransmitter release by the P2 receptor family can either be 
facilitatory or inhibitory (primarily mediated by P2Y) (Sperlagh et al., 2007).  The facilitatory 
action of presynaptic P2X receptors on acetylcholine release has been readily studied and 
confirmed by electrophysiological methods from motor nerve terminals of mice (Hong and 
Chang, 1998).  The secretion of excitatory neurotransmitters such as glutamate is also regulated 
by presynaptic P2X receptors, and has been reported in the hippocampus and brain stem (Khakh 
and Henderson, 1998; Pankratov et al., 2002; Khakh et al., 2003).  P2X receptors also promote 
the release of inhibitory neurotransmitters, specifically the major inhibitory neurotransmitter, γ-
aminobutyric acid (GABA).  Ubiquitously expressed ligand ATP was reported to facilitate 
GABAergic transmission between dorsal horn neurons (Hugel and Schlichter, 2000).  Also, ATP 
produces an elevation in the intracellular Ca
2+ 
levels in synaptosomes, resulting in the sequential 
release of GABA due to P2X3 receptor excitation (Gómez-Villafuertes et al., 2001).  Modulation 
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of GABA release by P2X receptors has also been identified in the hippocampus, brainstem and 
spinal cord (Sperlagh et al., 2007).  These findings encompass and appreciate the dynamic roles 
that P2X receptors play in neuromodulation and neurotransmission in the brain.  
1.4.2 The purinergic driven regulation of receptors expressed on the postsynaptic 
membrane  
 Calcium is able to regulate the function of many intracellular and membrane proteins.  One 
of the principle pathways of extracellular ATP action as a neurotransmitter is the modulation of 
postsynaptic receptors via a calcium dependent process as a result of their high calcium 
permeability.  A crucial functional aspect of P2X receptors is their capacity to interact with other 
receptors involved in neurotransmission.  In 1994, their ability to cross-talk with nicotinic 
acetylcholine receptors was demonstrated by Nakazawa et al.  Application of both ATP and 
acetylcholine led to the reduction in one of the currents activated by either agonist, therefore 
indicative of reciprocal inhibition in rat sympathetic neurons.  This novel study reported the 
dependence that activated acetylcholine and ATP receptor- mediated currents in neurons have on 
each other.  The reciprocal inhibition appeared to be significantly influenced by the degree of 
channel opening as the suppression of the current of one agonist was alleviated once the 
excitatory current evoked by the other agonist had been desensitised (Nakazawa, 1994).  
Consequently, intense research on the negative interaction between P2 receptors and other 
receptors may provide new insights into the purinergic driven neuromodulation on the 
postsynaptic membrane in the peripheral and central nervous systems.    
 NMDA glutamate receptors are inactivated as a result of Ca
2+
 signalling (Legendre et al., 
1993).  The mechanism underlying NMDA inactivation is highly complex, but it is understood 
that calmodulin and phosphatase B are involved (Krupp et al., 1999).   In this context, since Ca
2+
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signalling through P2X receptors can influence the activity of NMDA receptors, perhaps they 
modulate the function of NMDA receptors in areas of the CNS where both glutamate and ATP 
are co-released (Burnstock, 2004).  In hippocampal pyramidal neurons activation of P2X 
receptors by ATP binding produced a Ca
2+
-dependent inactivation of the residing NMDA 
receptors (Pankratov et al., 2002a), which also involved the activation of an intracellular 
signalling cascade.  This was demonstrated after short applications of ATP generated an acute 
decline in the amplitude of the NMDA-mediated excitatory postsynaptic currents (EPSCs).  
Moreover, NMDA evoked EPSCs in hippocampal CA1 neurons were hindered in the presence of 
P2X mediated currents.  The study demonstrated that the introduction of a Ca
2+ 
chelator called 
EGTA to the recording pipette eliminates the purinergic driven modulation of NMDA receptors 
(Pankratov et al., 2002a).   
1.5 P2X and GABAA receptor interactions in the peripheral and central nervous systems 
1.5.1 Molecular biology of GABAA receptors 
  GABA (γ-aminobutyric acid) is the predominant inhibitory neurotransmitter present in the 
central nervous system (CNS).  These receptors assemble as heteropentameric glycoprotein 
complexes that can be formed from six different subunits with varying members present to 
produce the receptor: α (1-6), β (1-3) γ (1-3), δ, ε, and θ subunits (Persohn et al., 1992; Brandon 
et al., 2000).  Oligonucleotide labelling studies have located GABA receptor units expressed in 
the cerebellum, hippocampus, cerebral cortex, thalamus, substantia nigra and spinal cord 
(Persohn et al., 1992).  The composition of the receptor subunits has significant effects on the 
pharmacology and physiological functions of GABAA receptors in the CNS.   
 Research suggests that there are considerable variations in the pharmacology and subunit 
expression of the GABAA receptors expressed in embryonic and adult DRG neurons (Maddox et 
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al., 2004).  Activation of GABAA receptors by agonists pentobarbital and diazepam suggests the 
incidence of ,,-containing receptors, as such both embryonic and adult DRG neurons elicited 
GABAA currents after the application of 50M of pentobarbital (Valeyev et al., 2000).  
However, adult DRG neurons were not sensitive to GABAA receptor antagonists picrotoxin or 
bicuculline, suggesting age related pharmacological differences of GABA receptors expressed on 
DRG neurons.  Ionotrophic GABAC receptors cannot be suppressed by bicuculline due to their  
subunit composition.  The inability of bicuculline and picrotoxin to inhibit GABAA receptors on 
adult DRG neurons signifies the presence of receptors entirely assembled of  subunits, yet 
currents were still potentiated by pentobarbital which favours ,,-containing receptors 
(Maddox et al., 2004).  Dissimilarly, embryonic DRG neurons were sensitive to picrotoxin and 
bicuculline, thus suggesting the presence of a novel GABAA subunit composition residing on 
adult DRG neurons.  Interestingly, GABAA subunits 2 and 3 are expressed on adult DRG 
neurons (Maddox et al., 2004), which previously highlighted the importance of GABA subunit 
composition in another study (Boue-Grabot et al., 2004). 
1.5.2 GABAA receptors and calcium modulation 
 Studies confirm that the release of neurotransmitter from GABAergic synapses is 
profoundly reliant on Ca
2+
 signalling in the CNS (Stefani et al., 1994).  Whilst conducting our 
experiments variations in the control GABA responses were identified, which were more 
profound in high Ca
2+
 concentrations (ref. Chapter 3, Fig. 3.2.1:12a)  Mozrymas’ group 
documented that changes in the concentration of intracellular calcium in hippocampal neurons 
affects the desensitisation kinetics of the GABAA receptor and observed a run-down of the 
GABA receptor-mediated current (Mozrymas and Cherubini, 1998).  The run-down was 
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markedly greater at higher Ca
2+ 
concentrations.  Also, it was noted that the run-down was 
accompanied by alterations in the desensitisation kinetics of the GABAA receptor.  Analysis 
revealed that the diminishing current was attributable to intracellular Ca
2+ 
and not due to an 
influx through voltage-dependent channels.  These results suggest that the run-down in the 
GABA receptor-mediated currents is due to the activation of calcium dependent enzymes, which 
regulate the phosphorylation of the receptor and thus signalling potential of GABAA receptors 
(Mozrzymas and Cherubini, 1998).  Currently, the agonist interactions of GABAA are well 
defined but the intracellular modulation of this ionotrophic receptor is yet to be fully understood.   
 Amounting evidence suggests that GABAA receptor mediated responses can be influenced 
by phosphorylation, kinases and intracellular Ca
2+
 (Stelzer, 1992).  It has been reported that 
activation of Ca
2+
/calmodulin-dependent phosphatase, calcineurin, suppresses GABAA receptor-
mediated currents (Chen et al. 1990) and kinases such as, Ca
2+
/calmodulin dependent protein 
kinase II (CaMK II), potentiates GABAA receptor responses (Wang et al., 1995).  The 
importance of phosphorylation in the maintenance of receptor function was manifested when 
phosphorylating factor, Mg-ATP, was absent from the intracellular solution and 
dephosphorylation governed the GABAA receptor run down (Chen et al., 1990).  Nevertheless, 
under the conditions of high intracellular Ca
2+
 the suppression was more profound even in the 
presence of Mg-ATP.  In fact, perfusion of low Ca
2+
 solutions always occluded the diminution of 
the response generated by high Ca
2+
 solutions, indicative of the reversibility of the run down.  In 
this context, the GABAA receptors can seemingly exist in two different states: phosphorylated 
(functional) or dephosphorylated (non-functional).    
 The dephosphorylation/phosphorylation cycle that occurs as part of the intracellular 
modulation of GABAA receptors can be regulated by the activation of specific receptors. The 
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influx of Ca
2+
 through ligand gated receptors such as NMDA causes an increase in the level of 
intracellular Ca
2+
, suppressing the GABA current.  Interestingly, this action is eradicated via the 
introduction of calcineurin inhibitors (Chen et al., 1990).  The activation of calcineurin results in 
the loss of the phosphorylated functional receptor, however the identification of the specific 
kinase that mediates the phosphorylation of GABAA is not known.  In contrast, influx through 
Ca
2+
 permeable 5-HT3 channels facilitates GABA release in the hippocampus (Turner et al., 
2004), but still emphasises the influence of intracellular calcium in this innovative mechanism.   
 In this context the Ca
2+
 plays a direct role in the modulation of GABAA receptors by 
promoting the activation of intracellular messenger cascades to which the receptors act as 
substrates.  As yet, the functional relationship between a reduction in Ca
2+
 and the subsequent 
reduction in synaptic current arbitrated by GABAA receptors has not been identified.  However, 
it could potentially have an impact several physiological and neuropathological mechanisms.  
These prospective processes range from synaptic plasticity, seizure activity associated with 
epilepsy and the efficacy of certain drugs  (Mozrymas and Cherubini, 1998). 
1.5.3 P2X receptor driven down-regulation of GABAA receptors 
 A potential role of P2X receptors as a consequence of their high affinity for Ca
2+
 ions could 
be the purinergic driven modulation of GABAA receptors.  Their capacity to sequester high 
concentrations of calcium inside a cell could activate Ca
2+
/calmodulin dependent phosphatases 
or kinases to modulate the GABAA receptor function, expanding the repertoire of P2X receptors 
modulatory roles in the central nervous system.  
 Previous  results have established that the reciprocal inhibition between P2X and GABAA 
receptors can transpire on cultured rat dorsal root ganglion (DRG) neurons of the peripheral 
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nervous system (Sokolova et al., 2001).  This pioneering study highlighted the ability of 
excitatory P2X-mediated currents to occlude propagating inhibitory GABAA receptor currents.  
Occlusion was elevated in the presence of intracellular Ca
2+
.  Therefore, the results suggest a 
novel Ca
2+ 
dependent interaction between P2X and GABAA receptors on DRG neurons 
(Sokolova et al., 2001).  
  Boué-Grabot et al. (2004), demonstrated the concurrent activation of both P2X2 and 
multiple GABAA receptors expressed in Xenopus oocytes, results in cross-inhibition.  This 
inhibition was heavily reliant on the composition of the GABAA receptor subunits, as P2X2 
receptors failed to suppress currents mediated by GABAA receptors composed of 2 or 3 
subunits (Boue-Grabot et al., 2004).  This particular study disputes the concept that P2X3 
receptors can occlude GABAA receptor mediated currents as proposed by Sokolova et al. (2001).  
Moreover, a later study by the same research group suggests that the mechanism underlying the 
reciprocal inhibition between the receptors is independent of Ca
2+
, but occurs via direct 
interactions between the intracellular domains of P2X2, P2X3 or P2X2/3 receptors in the 
peripheral nervous system and P2X4 in the central nervous system with GABA (Boue-Grabot et 
al., 2004; Toulme et al., 2007; Jo et al., 2011).  A similar mechanism has been described for the 
interactions between the dopamine D1 receptor and the glutamate receptor NMDA (Salter, 2003; 
Toulme et al., 2007).  Hence, research into the GABAA and P2X receptor interaction is ever 
expanding and the underlying mechanism to this receptor communication remains controversial.  
The balance between inhibitory neurotransmission which is maintained primarily by 
GABAA receptors and excitatory neurotransmission for which AMPA receptors are 
predominantly responsible is crucial for the functioning of the central nervous system.  
Dysfunctional GABA receptors have been implicated in the pathophysiology of many 
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neurological disorders such as anxiety, insomnia, epilepsy and schizophrenia (Spigelman et al., 
2002; Mohler et al., 2012; Mohler et al., 2005).  As targets of purinergic modulation they 
represent a novel pharmacological tool which could hold immense therapeutic potential.  
Therefore, one of the main objectives of this project was to understand the underlying 
mechanisms involved in this cationic and anionic receptor communication, which have yet to be 
explored.   
1.5.4. Modulation of GABA-ergic inhibition by glial cells 
 Once a neurotransmitter is released into the synaptic cleft it is rapidly removed by uptake 
mechanisms or can be removed by enzymatic processes, which are involved in the synthesis and 
degradation of the neurotransmitter as in the case of acetylcholine which is rapidly degraded in 
the synapse by acetylcholinesterase. Residual neurotransmitter in the synaptic cleft must be 
terminated quickly to prevent the occurrence of excitoxicity and neuronal cell death.  
GABAergic neurotransmission is ceased by uptake mechanisms into neuronal or astroglial cell 
compartments via GABA transporters.  A similar method of neurotransmitter recycling has also 
been demonstrated for glutamatergic neurotransmission.  Astroglial glutamatergic transport 
predominates over neuronal uptake, whereas GABA uptake is primarily via neuronal 
mechanisms.  However, the metabolism of neurotransmitters by astroglial cells is an important 
concept to the fundamental functioning of neurotransmission as dysfunctional neurotransmitter 
transport can have damaging results. 
 The transport of glutamate and GABA is far more complex than the general degradation of 
other neurotransmitters by enzymes and re-uptake into the presynaptic terminal as astrocytes are 
significantly involved.  Astrocytes express the biological machinery to control the availability of 
the precursors to produce GABA and glutamate (Schousboe and Waagspetersen, 2003).  In the 
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central nervous system excitatory neurons responsible for the release of glutamate are strongly 
dependent on the release of glutamate precursors from astrocytes, which are used to synthesise 
glutamate after neuronal uptake.  Any interruption in the astroglial release of these precursors, 
specifically glutamate synthetase and pyruvate carboxylase which are only expressed in glial 
cells, results in the elimination of glutamatergic neurotransmission (Schousboe and 
Waagspetersen, 2003).   
 GABA homeostasis is regulated by GABA transporters which are expressed on neurons 
and astrocytes (Shigetomi et al, 2012).  To date four transporters have been cloned GAT1-4 
(Schousboe and Kanner, 2002).  The role of the GABA transporters which are responsible for 
keeping extracellular GABA concentrations low has been demonstrated when GABA transporter 
inhibitors caused enhanced levels of GABA in the synaptic cleft.  Glial cells express GAT1, 
GAT2 and GAT4 and thus are prime candidates for the removal of GABA from the synapse.  
Residual GABA that isn’t recycled by neurons is taken up by astrocytes where it is then oxidised 
or transported back to neurons via the GABA-glutamine-glutamate shuttle.  Glutamine is a 
metabolite of glutamate and is exclusively expressed in astrocytes (Broer and Brookes, 2001).  
Astrocytes are unable to convert glutamate into GABA by the modulation of enzymes; 
alternatively glutamine plays the role of a precursor of GABA from the breakdown of glutamate.  
Glutamine is transported to GABAergic nerve terminals where it is metabolised to produce 
glutamate and then undergoes decarboxylation to form GABA, which is regulated by enzyme 
glutamate decarboxylase.  
 The role of astroglial cells on the modulation of GABA homeostasis is intensively studied.  
Homeostatic mechanisms to ensure that the levels of extracellular GABA remain low are 
significant for the survival of neurons and the maintenance synaptic transmission.  Another 
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purpose for the regulation of GABA receptor uptake by neurons and astrocytes is for the 
preservation of the fine balance that exists between GABAergic and glutamatergic 
neurotransmission.  Any alterations in this balance between inhibitory and excitatory 
transmission can lead to a host of neurological disorders, primarily linked to epilepsy.  
Therefore, much research has concentrated on the potential of inhibitors which block GABA 
uptake in glial cells as prospective therapeutic agents for epilepsy (Schousboe et al., 2003).   
1.5.5 Tonically active GABAA receptors in the central nervous system 
 GABAA receptors are also involved in another important mechanism in the central nervous 
system called tonic inhibition.  Not only do GABAA receptors respond to the local release of 
GABA from the presynaptic membrane, but they also respond to a persistent tonic current caused 
by a spill over of neurotransmitter from the synaptic cleft.  Tonic GABAA receptors are 
kinetically and pharmacologically distinct from their phasic counter parts that give rise to the 
traditional miniature inhibitory post synaptic currents (mIPSCs).  Initially documented in 
cerebellar granule cells (Brickley et al. 1996; Wall et al. 1997; Hamann et al 2002) a transient 
tonic conductance has also been observed in multiple brain regions: hippocampus, thalamus, 
dentate gyrus, striatum, spinal cord, hypothalamus and neocortex (Yamada et al., 2007; Krook-
Maguson et al., 2008; Belelli et al., 2009).  In parallel with the incidence of tonic inhibition is the 
expression of a special subset of GABAA receptor subunits, which are specific to tonic GABAA 
receptors.  These receptor subunits particularly expressed on neurons in the cerebellum and 
dentate gyrus include α6 and δ GABAA receptor subunits and α1 in the neocortex (Yamada et al., 
2007).  The differences in GABAA receptor subunit composition and brain region specificity can 
give rise to significantly distinct phasic and tonic GABAA receptors in the central nervous 
system.  Immunohistochemical studies have demonstrated the extrasynaptic nature of the δ 
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subunit, but not all tonic GABAA receptors necessarily express δ subunits (Yamada et al., 2007).  
However, the important characteristics of the δ-subunit such as its high GABA sensitivity, 
extrasynaptic location and slow desensitization kinetics make it the perfect candidate for its 
involvement in tonic inhibition. 
 The physiological role of tonic GABAA receptors in the central nervous system is far from 
understood.  It has been implicated in the control of neuronal firing patterns and excitability 
(Hamann et al., 2002; Semyanov et al., 2003) and it has also been demonstrated that impairments 
in tonic inhibition is involved in many neurological disorders such as Fragile X Syndrome, 
stress, idiopathic and temporal lobe epilepsy (Belelli et al., 2009).  Since tonically active GABAA 
receptors are prime targets for various reagents (Santhakumar et al., 2007) it is highly possible 
that they could act as novel therapeutic targets for a plethora of neurological pathophysiologies.  
Although it has been suggested that tonic inhibition occurs on neocortical pyramidal neurons 
(Yamada et al., 2007) the underlying mechanism and the physiological relevance of this 
phenomenon is far from being elucidated.  
1.6 Modulation of synaptic plasticity by post-synaptic P2X receptors 
  Various methods of increasing synaptic strength exist; long-term potentiation (LTP) is 
currently at the forefront of brain and behaviour research due to their contribution to learning and 
memory (Malenka and Bear 2004; Hansel et al. 2008).  These two mechanisms can be mediated 
presynaptically by modifying neurotransmitter release or postsynaptically by the trafficking of 
receptors to and from the cell membrane.  Our understanding about the role of P2X receptors in 
synaptic plasticity is relatively poor.  However, some experiments have demonstrated the 
participation of P2X in synaptic plasticity in the CNS.  For example, Yamazaki et al. (2003) 
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showed that application of ATP onto hippocampal CA1 neurons elicited LTP in neurons 
showing small Ca
2+ 
currents, whereas LTD was detected in neurons exhibiting larger Ca
2+ 
currents.  Thus, there was a considerable correlation between the enormity of the long-term 
changes in plasticity and the size of Ca
2+ 
signals following ATP application (Yamazaki et al. 
2003).  Broadly, agonists of P2X may generate modifications in synaptic strength by themselves, 
which may occur via cell death or brain trauma when large amounts of ATP is released 
(Pankratov et al. 2008).                     
 The effects that P2X purinoreceptors have on synaptic plasticity can be clearly 
subdivided into either positive or negative categories.  For instance, the inhibition of P2X 
receptors induces LTP, however P2X failed to facilitate LTP when NMDA receptors were 
suppressed (Pankratov et al. 2002a).  Legendre et al. (1993) postulated that NMDA receptors can 
be inactivated via a Ca
2+ 
dependent mechanism.  This suggestion represents a viable system as to 
how P2X receptors can aid LTP initiation.  Whereby, activated P2X receptors inhibit adjacent 
NMDA receptors causing an elevation in the threshold value to initiate LTP (Pankratov et al. 
2008).  In contrast, some evidence is indicative that ATP is able to augment LTP in the CNS (i.e. 
a positive effect).  A positive modulator of P2X4 receptors, ivermectin, potentiates ATP currents 
and enhances LTP in wild-type mice but not in P2X4 receptor knock-out mice (Sim et al. 2006).  
Additionally, it has recently been discovered that activation of P2X receptors on the postsynaptic 
terminal by astroglial ATP causes the insertion of postsynaptic AMPA receptors in hippocampal 
neurons  (Gordon et al. 2005).  It has been suggested that P2X7 receptors were responsible as it 
is closely linked to phosphatidylinositol 3-kinase (Jacques-Silva et al. 2004), which is essential 
for AMPA receptor insertion (Man et al. 2003).  Therefore, this particular study demonstrated 
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the possibility that ATP can produce enduring changes in the efficiency of the postsynaptic 
membrane.   
A crucial functional aspect of P2X receptors is their capacity to interact with other 
receptors involved on neurotransmission.  In 1994, their ability to cross-talk with nicotinic 
acetylcholine receptors was demonstrated by Nakazawa et al.  Application of both ATP and 
acetylcholine led to the reduction in one of the currents activated by either agonist, therefore 
indicative of reciprocal inhibition in rat sympathetic neurons.  This novel study reported the co-
dependence of activated acetylcholine and ATP receptors on neurons.  The reciprocal inhibition 
appeared to be significantly influenced by the degree of channel opening as the suppression of 
the current of one agonist was alleviated once the excitatory current evoked by the other agonist 
had been desensitised (Nakazawa, 1994).  Consequently, intense research of negative interaction 
between P2 receptors and other receptors may provide new insights into neuromodulation on the 
postsynaptic membrane in the peripheral and central nervous systems.    
NMDA glutamate receptors are inactivated as a result of propagating Ca
2+
 currents 
(Legendre et al., 1993).  The mechanism underlying NMDA receptor inactivation is highly 
complex, but it is understood that calmodulin and phosphatase B are involved (Krupp et al. 
1999).   In this context, since Ca
2+
 signalling through P2X receptors can influence the activity of 
NMDA receptors, perhaps it regulates the functioning of these receptors in areas of the CNS 
where both glutamate and ATP are co-released (Burnstock, 2004).   In hippocampal pyramidal 
neurons activation of P2X receptors by ATP binding produced the Ca
2+
-dependent inactivation 
of the NMDA receptors (Pankratov et al., 2002a).  This was demonstrated after short 
applications of ATP generated an acute decline in the amplitude of the NMDA receptor-
mediated excitatory currents.  Moreover, NMDA receptor evoked EPSCs in hippocampal CA1 
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neurons were hindered in the presence of P2X receptor-mediated currents.  A Ca
2+ 
chelator and 
P2X specific inhibitor PPADS eliminates P2X-mediated inhibition of NMDA receptors 
(Pankratov et al., 2002a).   
1.7 The physiological relevance of extracellular ATP 
Many studies have demonstrated the modulatory action of the purinergic receptors on the 
presynaptic membrane.  The action of extracellular ATP on postsynaptic receptors, especially in 
native cells remains relatively unexplored.  Current research suggests that the P2X 
purinoreceptors are able to influence synaptic plasticity, synaptic transmission and brain 
function; however the underlying mechanisms of such modulatory processes are far from being 
defined.   
P2 purinoreceptors are widely expressed on glial cells in the central nervous system.  A 
glial cell subtype, astrocytes are able to integrate in to the synapse and provide functional 
support to neighbouring neurons.  Research has primarily focused on the role of astroglial 
metabotropic P2Y receptor derived calcium signalling and its impact on synaptic transmission.  
However, there is evidence in support of calcium signals mediated by the ionotrophic P2X1/5 
receptors (Palygin et al., 2010) which are specific to astroglial cells.  Therefore, activated P2X 
receptors expressed on astrocytes could be mediators of localised bi-directional communication 
between neurons and glial cells.   
The generation of calcium signals by the release of extracellular ATP from astrocytes and 
neurons upon activating P2X receptors provides the foundations for a novel form of modulation 
of synaptic activity.  Currently, other putative pathways of glial regulation, like the modulation 
of the activity of postsynaptic GABA receptors by gliotransmitters remain almost unexplored.   
Since it is well known that the pathophysiologies of many neurological diseases stem from 
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dysfunctional synaptic transmission and that gliotransmitters can regulate synaptic signalling, it 
is important to study of the role of purinergic modulation on postsynaptic receptors.  Otherwise, 
the role of ATP as part of the tripartite synapse and its potential pharmacological consequences 
for the treatment of neurological diseases cannot be fully understood.   
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Chapter 2 
 
Materials and Methods 
 
2.0 Peripheral neurons 
 The dorsal root ganglion (DRG) neurons of the peripheral nervous system were prepared 
using 8-20 day old CBL57 mice, which were decapitated and then dissected to allow precise 
extraction of the DRG ganglia.  The ganglia were then placed in a solution consisting of (mM): 
150 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2 and 10 HEPES, pH adjusted to 7.3 with NaOH.  Enzymatic 
treatment of the ganglia was carried out using the same solution with a lower calcium 
concentration (0.5 mM) containing 1.2 mg/ml of protease type XIV and incubated at 34
O
C for 15 
minutes.  Once removed from the enzymatic treatment the ganglia are subsequently transferred 
back to the solution consisting of a normal calcium concentration (Lalo et al., 2001) and then 
kept for up to 8 hours for experiments.  DRG neurons were isolated using the conventional 
trituration method using fire polished pipettes with tip diameters that ranged from 200-500 µm 
(Lalo et al., 2001). 
2.1 Central neurons 
 Whole-cell recordings were made from acutely isolated pyramidal cells of the 
somatosensory cortex.  Slices were prepared from 15-30 day-old CBL57 mice that were 
anesthetised using haloethane and immediately decapitated in agreement with the UK Home 
Office legislation.  Once the brain was removed it was divided into two hemispheres in the 
coronal plane.  The brain was placed in the slicing chamber and gassed with a 95% O2/5% CO2 
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mix.  Slices were cut to a thickness of 300-350 µm in physiological saline at a temperature of 
4°C to prevent tissue degradation.  The preparation of the slices is similar to a previously 
described procedure (Lalo et al., 2006). 
After the slices were prepared they were incubated in a chamber at room temperature for 
a minimum of two to four hours in physiological saline (mM) 130 NaCl, 2.7 KCl, 1 MgCl2, 2.5 
CaCl2, 18 NaHCO3, 1 NaH2PO4 and 15 glucose, pH 7.3 when gassed with a 95% O2/ 5% CO2 
mix until they were ready for isolation.   
2.2 Cell isolation 
Cells were isolated at room temperature from layer 2/3 of the somatosensory cortex.  We 
used a non-enzymatic acute isolation procedure called vibrodissociation  (Vorobjev, 1991; Lalo 
et al., 2006; Jun et al., 2011).  This procedure involves suspending a pre-incubated slice in 
artificial saline inside the recording chamber which acts as a suitable culture dish for visualising 
the slice under a dissecting microscope.  The slice is stabilised and held in place by a modified 
platinum wire approximately 0.5 mm in diameter, which has been moulded to specifically fit 
mouse brain slices.  
A vibrating glass ball (diameter of 100-200 µm) attached to a flame sealed micropipette 
is moved slowly (20-50 µm) over the slice surface using a micromanipulator, vibrating at 100 
Hz. (Fig. 2.2:2).  The vibrating glass ball is moved laterally, deeper through the entire brain 
tissue in the desired area.  This step is repeated to maximise the number of cells isolated from the 
specific brain region for experimental use.  The external solution used for cell isolation included 
(mM): 140 NaCl, 2.7 KCl, 1 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 18 NaHCO3 and 15 glucose, pH-
adjusted to 7.3 with NaOH.   After cell isolation the platinum wire and remaining brain slice are 
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omitted and the cells are left suspended in the solution until they sink to the bottom of the 
recording chamber and then they are ready for experimental use.  
This innovative technique is useful as it preserves the cell dendrites and enables specific 
isolation of neurons even from older animals; it also prevents the possible impact of an enzyme 
on membrane proteins (Fig. 2.2:3).  The mechanical isolation of native cells has many 
advantages over the use of cultured cells and cell lines as the "natural" receptor composition and 
physical arrangement of receptors is retained on the neurons.  Also, there is the absence of 
adverse effects such as excitotoxicity, related to the excessive density of receptors, which can be 
typical for cell lines.  Most studies which focus on the impact of P2X receptors on synaptic 
transmission and neuromodulation employ expression systems and cultured cells, however the 
series of experiments outlined in this current project uses native cells, emphasising the novelty 
and originality of our work. 
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Figure 2.2:3.  Photographs taken of the vibrodissociation setup used throughout the experiments 
conducted on acutely isolated cortical pyramidal neurons. 
A vibrating glass ball is passed over the dissected coronal brain slice in regions L2/3 of the 
somatosensory cortex enabling the dissociation of neocortical neurons from the brain tissue for whole-cell 
patch clamp recording.   
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Figure 2.2:4.  Examples of acutely isolated cortical L2/3 pyramidal neurons using the 
vibrodisscocation technique. 
The acute isolation procedure preserves the dendrites and synaptic terminals of the pyramidal neurons and 
prevents any possible impact to membrane proteins by other enzymatic isolation methods.  
 
 
 
 
  
45 
 
2.3 Electrophysiological recordings 
Whole-cell patch clamp recordings from isolated cortical pyramidal neurons in cortical 
layers II/III of brain slices were measured using an Axopatch 200B (Axon Instruments, USA) 
patch clamp amplifier.  The membrane potential was voltage clamped at -80 mV and 
continuously perfused (1.5-2 ml/min) with an extracellular solution containing in mM: 140 NaCl, 
2.7 KCl, 1 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 18 NaHCO3 and 15 glucose, pH-adjusted to 7.3 with 
NaOH.  Recordings were made using patch pipettes which were pulled using boroscillicate glass 
electrodes complete with filaments (World Precision Instruments), with resistances between 3-5 
M  when filled with an intracellular solution containing (mM): 120 CsCl, 20 HEPES, 1 MgCl2, 
3 Mg2ATP3, and 10 EGTA, pH-adjusted to 7.3 with CsOH.  The intracellular calcium 
concentration of the cells was adjusted using high (10 mM) and low (0.2 mM) levels of calcium 
chelator, Ethylene Glycol Tetra-acetic Acid (EGTA). 
The membrane potential was clamped at -80 mV unless otherwise stated and currents 
were filtered at 3 Hz.  Liquid junction potentials were compensated using the patch-clamp 
amplifier.  We did not use series resistance compensation because the cells were not of rounded 
shape and had dendrites typically, so compensation would not have been adequate.  Also, the 
recorded current was not of a large amplitude and the series resistance was not very large so it 
did not bring significant error in the membrane potential.  To monitor the cells viability and to 
ensure that it was still useful for experimental purposes a voltage step from -80 to -20 mV was 
routinely observed between fast applications of GABA in central neurons (Fig. 2.4:5).  The 
response to the voltage-step is comprised of currents generated by voltage gated Na
+
- and Ca
2+ 
channels.  The absence of a Na
+ 
current in response to the voltage-step would suggest that the 
cell is no longer suitable for voltage clamp experiments. 
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Field Excitatory Postsynaptic Currents (fEPSPs) were recorded in neocortical layer III 
with glass microelectrodes filled with artificial CSF (1-2 M) (Pankratov et al. 2002b).  
Approximately 15 minutes before the delivery of the stimulus was allowed to ensure that the 
baseline had stabilised.  The induction of LTP was caused by delivering trains of high frequency 
Theta Burst Stimulation (TBS).  The intensity of TBS ranged from minimal, 20-30% below the 
threshold required to induce LTP to maximal which produced potentiation in nearly all cells 
tested.     
2.4 Whole-cell patch clamp  
During patch clamp recording an electrode made from a glass filament is sealed to an 
area of the cell membrane, which contains a small population of ion channels.  The electrode 
used consists of a small tip often with an opening less than 1 µm.  During our experiments the tip 
of the glass electrode was heated in a microforge to ensure that an even and smooth surface is 
produced which facilitates the formation of a membrane giga seal of a high resistance.   
 An intracellular solution is placed inside the glass filament of the pipette and makes 
contact with the silver wire that is attached to the head stage and amplifier, which records 
changes in ion flow across the membrane.  The intracellular solution is of a similar composition 
to the extracellular solution that is perfused to the recording chamber, but can be modified to 
include specific drugs to change the recording conditions, for example when examining 
intracellular calcium signalling in cortical astrocytes (Palygin et al., 2010).   
 The recording electrode is lowered towards the cell and placed upon the cell membrane.  
To help form a giga seal between the electrode and the cell membrane negative pressure is 
applied which forces a patch of the membrane to make contact with the tip of the electrode.  As a 
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result of the high resistance of the seal, ionic currents can be isolated and measured with little 
noise and mechanical disturbance to the recording.   
 Whole-cell patch clamp recordings consist of recording multiple ionic currents within the 
area of the patched membrane from a small population of membrane receptors.  Once a giga seal 
is formed the position of the electrode on the cell membrane is maintained throughout the entire 
duration of the recording.  More negative pressure is applied in order to rupture the patched 
membrane.  When this occurs the intracellular solution moves into the cells cytoplasm and 
dialyzes the cell’s intracellular contents.  A reliable indicator which suggests that the cell 
membrane has been ruptured successfully and suitable for recording is the observation of a 
transmembrane current caused by the activation of voltage-gated Na
+
 channels.  In some cases 
the transmembrane current may also include responses mediated by K
+
 and Ca
2+
 voltage-gated 
channels which was documented in our experiments conducted on DRG neurons (Fig. 2.4:5).  
There are different forms of patch clamp recording methods.  The variation used 
throughout this project is called whole cell voltage-clamp (Lalo et al., 2009).  A holding voltage 
is set and uses a negative feedback mechanism contained inside the amplifier to clamp the cell at 
the desired voltage e.g. -80mV.  This allows the changes in the ionic conductance across the 
membrane to be measured which can be interpreted as a receptor response when specific receptor 
agonists are applied (Grubb and Evans, 1999; Lalo et al., 2004; Lalo et al., 2009).  
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Figure 2.4:5. Voltage-clamp recordings in isolated DRG neurons of the peripheral nervous system. 
A, example of transmembrane currents activated by series of voltage steps from -70 to 40 mV.  Responses 
mediated by voltage-gated Na- and K- currents demonstrate good voltage-clamp conditions and cell 
viability. B, transmembrane currents activated by application of ATP (10 µM).  The ATP currents 
coincide with observations made by Grubb and Evans (1999), a fast and rapidly inactivating current 
reminiscent of the P2X3 phenotype (left) and a slow sustained response, predominantly mediated by 
P2X2/3 receptors (right).  Currents were recorded in different cells at a holding potential of -80 mV.  
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Figure 2.4:6. Voltage-clamp recordings taken from acutely isolated cortical pyramidal neurons of 
the central nervous system.   
Examples of transmembrane currents activated by the application of P2X specific ATP analog α,βme-
ATP (10 µM) to cortical pyramidal neurons.  Again as observed in DRG neurons both receptor responses 
demonstrate different kinetically distinct phenotypes of the various homomeric and heteromeric P2X 
receptor complexes expressed in the central nervous system.  Currents were recorded in different cells at a 
holding potential of -80 mV.  
60 pA 
500 ms 
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2.5 Field Excitatory Postsynaptic Potential (fEPSP) Recordings  
Prepared slices were placed in the recording chamber and perfused with aerated artificial 
saline as the same composition as the incubating solution used to store slices before experiments 
commenced.  The extracellular solution was gassed with a 95% O2 and 5% CO2 mix.  The 
stimulating bipolar electrode (50m thick Ni/Cr) was positioned in layer IV-V of the neocortex 
whereas the recording microelectrode was filled with identical ACSF, which was superfused 
over the slice.  The recording microelectrode was positioned in layer II/III of the neocortex 
juxtaposed to the stimulating electrode, once a suitable fEPSP was found.  The amplitude of 
stimulation to layer IV-V ranged between 0.5 and 3 Amps which consequently produced an 
EPSP of approximately 60% of the amplitude of the maximal response to ensure that any 
possible potentiation in the EPSP amplitude would be observed.  Layer IV-V of the neocortex 
participates in callosal and ipsilateral corticocortical circuits (Hefti and Smith, 2000).  The 
placement of the recording electrode in layer II/III was for the consistency with previous 
experiments on pyramidal neurons, which were acutely isolated from the same region of the 
neocortex.  Layer II/III neurones receive vertical projections sent from neurones in layer IV/V 
(Feldman, 2000). Additionally, recording from this layer produced a clear EPSP which can be 
reproduced for more than two hours whilst recording, without any run-down.  A stable amplitude 
was recorded in approximately 80% of all cortical slices using this particular recording 
configuration. 
The induction of LTP was generated by utilising a standard Theta Burst Stimulation 
(TBS) protocol consisting of a 0.5 second train at 100Hz.  In total 5 trains were delivered with 10 
second intervals. Earlier experiments demonstrated that depending on the age of the animal 
shorter trains consisting of 2 or 3 were not sufficient to elicit LTP in the neocortex. Once the 
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baseline had stabilised after approximately 15 minutes a TBS of 5 pulses was applied to layer 
IV-V of the neocortex, producing an EPSP that reached a plateau lasting between 40-60 minutes 
each time.    
To study the role of astroglial derived ATP on LTP in the neocortex the standard TBS 
protocol was used repeatedly in the presence of various receptor agonists and glial cell toxins.  
After the baseline had stabilised the drugs were delivered 10 to 20 minutes before TBS was 
administered and washed out 0 to 60 minutes afterwards. 
2.6 Drug Delivery 
Agonists of P2X and GABAA receptors were applied at room temperature to acutely 
isolated single cells in the recording chamber by local perfusion via a rapid application system (5 
ms) controlled by an electromagnetic valve (Fig. 2.6:7).  Application of the receptor agonists to 
the patched neuron took approximately 2 seconds and applied at 3 minute intervals to prevent 
cumulative receptor desensitisation.  Protein kinase inhibitors and receptor antagonists were also 
applied by bath perfusion along with the extracellular solution at a rate of 2 ml/min.  In the case 
of allosteric modulator of δ-subunit GABA containing receptors, DS2, it was coapplied in the U-
tube along with GABA.    
Recording of receptor activated currents did not begin until the GABAA response had 
stabilised (ref. Chapter 3, Fig. 3.2.1:12).  Consecutive applications of GABA were carried out 
before the experiments began to ensure that the inevitable calcium-dependent run-down of 
GABA responses was taken into account, particularly in 0.2 mM EGTA concentrations. The 
pharmacological changes observed during the experiments are all relative to the control 
conditions (before the application of the P2X agonists).  The average of the GABA responses 
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recorded after the application of ATP were normalised to the control GABA responses.  This was 
done for every experiment and thus prevents an underestimation of the impact of the P2X 
receptor agonists on GABAA receptor-mediated currents that could be caused by the rundown in 
the GABA receptor responses. 
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Figure 2.6:7.  A schematic diagram showing an example of the U-tube set up that was implemented 
during experiments for drug applications to isolated pyramidal neurons of the neocortex. 
 
A, the rapid perfusion of drugs on to isolated cells is performed by a U-tube (B, left in the picture) which 
is controlled by an electromagnetic valve.  The advantages of using a rapid application system is that it 
allows a fast solution exchange time in the range of 5 ms and minimal drug consumption of < 50-100 
mL/application. C, shows an application test recording taken from a patched isolated neuron using 
distilled water to examine the performance of the U-tube.   Image A was adapted from Mortensen and 
Smart (2007).  
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2.7 Drugs 
All drugs were purchased from Tocris Bioscience or Sigma Aldrich if otherwise stated.  
2.8 Data analysis 
 
All data is representative as the mean ± s.d. (n = number of cells) and statistical 
significance of the results was determined using the Student’s t-test where necessary.  The 
figures used to present the experimental results were created using Origin 6.0.  A concentration 
response curve for the different GABAA receptor sensitivities to varying concentrations of 
GABA receptor agonist ranging from 0.1-200 µM were fitted to: 
I/Is=1/(1+(EC50/[C]
n
)
 
I = the current produced in GABA concentration [C] 
Is = concentration of agonist which causes saturation of the receptors (in our case 200 µM 
GABA) 
EC50 = the concentration of the agonist that generates a half maximal response 
n= Hill coefficient  
When trying to fit a single sigmoidal curve to the concentration response curve an 
unsatisfactory fit was produced due to the biphasic nature of the GABA concentration response 
curve (ref. Chapter 4, Fig. 4.1:19).  A range of GABA concentrations were used to activate the 
two different populations of GABAA receptors that are expressed in the central nervous system.  
They exhibit distinct levels of sensitivity to GABA, which is dependent on their location in the 
synapse.  As a result, the formation of two separate sigmoidal curves which amalgamated both 
the tonic and phasic components of the concentration response curve produced a much better fit 
(Fig. 2.8:8).  
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Figure 2.8:8.  Concentration response curves for two different population of GABAA receptors 
expressed on cortical pyramidal neurons in the central nervous system.  
A, phasic GABAA receptors respond to the local release of GABA from the presynaptic membrane.  This 
subtype of GABAA receptor has a lower affinity for GABA and is activated by higher agonist 
concentrations.  B, the activation of a different subset on GABA receptors, which is mediated by a 
persistent tonic current via a spill-over from the synaptic cleft.  They have a significantly higher affinity 
for GABA than the phasic receptor subtype and thus require a lower concentration of agonist for 
activation.  The responses represent the mean ± amplitude of response of GABA at different 
concentrations.  
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To monitor any changes in the amplitude of the excitatory postsynaptic potentials the 
slope of the fEPSPs was analysed using an orthodox method used previously in other studies 
(Fig. 2.8:9) (Fujii et al., 1995).  The effects of the drugs on LTP were analysed by changes in the 
slope of the field EPSP (fEPSP) before and after the drug application.  A linear approximation 
and mean square root analysis was used to calculate the slope of the rising phase of the EPSP.   
For each experimental protocol time courses were produced, an average of 6 consecutive 
individual EPSPs was recorded per minute.  The data was normalised at a control value which 
was defined as the period before LTP induction and when the baseline was stable, referred to as 
100%.  Approximately 6-12 experiments of the normalised time courses were averaged.  The 
data represents the mean +/-SEM.  
The slope of the fEPSPs was considered statistically significant for each experiment by 
comparing the level of potentiation to the 100% control, verified by the one-population t-test. 
Differences between the levels of LTP to control conditions were determined by the two-
population student t-test.  
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Figure 2.8:9.  fEPSPs recorded under control conditions and after administering a standard Theta 
Burst Stimulation protocol used throughout all of the experiments conducted in the neocortex.   
The initial spike of the fEPSP trace is the stimulus artefact produced by the stimulating electrode placed 
in layer IV-V. The rising phase of the excitatory postsynaptic potential is representative of the presynaptic 
volley which is caused by activity at the presynaptic nerve terminals; however the downward phase is 
indicative of postsynaptic potentials which gradually return back to baseline.  One minute after TBS is 
applied (red) to the slice there is a dramatic increase in the amplitude of the EPSP with also a notable 
change to the slope which becomes significantly steeper and the EPSP wider.  The EPSP eventually 
stabilises and 60 minutes after TBS (blue) application the amplitude of the EPSP decreases, but is still 
two-fold larger in amplitude than the control, before TBS (black).  Therefore, the standard TBS protocol 
is able to generate long term changes in the amplitude of the EPSPs, suggesting that long term 
potentiation has been induced.   
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Chapter 3 
 
P2X receptors down-regulate GABAA 
mediated currents in the peripheral and 
central nervous systems 
 
3.0 Introduction 
 P2X receptors are ligand-gated ionotrophic receptors activated by ATP, which can 
transmit robust Ca
2+
 signals to neurons and glial cells in the central nervous system. The P2X 
receptors high affinity for calcium is principal to their capability to modulate other receptors 
involved in neurotransmission on the postsynaptic membrane.  In 1994, their ability to cross-talk 
with nicotinic acetylcholine receptors was demonstrated by Nakazawa (1994).  Application of 
both ATP and acetylcholine led to the reduction in one of the receptor-mediated currents 
activated by either agonist, indicative of reciprocal inhibition in rat sympathetic neurons.  This 
novel study reported the dependence of activated acetylcholine and ATP receptors have on each 
other in neurons (Nakazawa, 1994).  Consequently, intense research in to the negative interaction 
between P2 receptors and other receptors may provide new insights into neuromodulation on the 
postsynaptic membrane in both the peripheral and central nervous systems.    
 Preliminary data proposes that reciprocal inhibition between cationic P2X and anionic 
GABAA receptors occurs on cultured rat dorsal root ganglion (DRG) neurons (Sokolova et al., 
2001).  Indeed, this pioneering study revealed the potential of P2X receptor-mediated currents to 
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occlude propagating GABAA receptor currents.  Occlusion was significantly elevated in the 
presence of intracellular Ca
2+
.  Therefore, this study suggests a novel Ca
2+ 
-dependent interaction 
between P2X and GABAA receptors transpiring on DRG neurons (Sokolova et al., 2001).  
 Boué-Grabot et al. (2004) demonstrated that the concurrent activation of both P2X2 and 
multiple GABAA receptors expressed in Xenopus oocytes results in the inhibition of GABAA 
receptor-mediated responses.  This inhibition was strongly reliant on the composition of the 
GABAA receptor subunits, as P2X2 receptors failed to suppress currents mediated by GABAA 
receptors composed of α, β, and 2 or 3 subunits (Boue-Grabot et al., 2004).  This particular 
study disputes the concept that P2X3 receptors can occlude GABAA receptor evoked currents as 
proposed by Sokolova et al. (2001).  Moreover, a later study suggests that the mechanism 
underlying the purinergic modulation of GABAA receptors is independent of Ca
2+
, but 
interactions between the intracellular motifs of P2X2, P2X3, P2X2/3 or P2X4 receptors with 
GABAA, (Boue-Grabot et al., 2004; Toulme et al., 2007; Jo et al., 2011) as with D1 and NMDA 
receptors (Salter et al., 2003).  Hence, research into GABAA and P2X receptor interactions is 
ever expanding and the apparatus inducing receptor cross-talk is far from being clarified.   
3.1 Inhibition of GABAA receptor currents by ATP and α,βme-ATP expressed on DRG 
neurons 
The application of either ATP and P2X receptor specific agonist α,β-meATP significantly 
reduced the GABA receptor-mediated responses.  ATP analogue α,β-meATP is described as a 
non-anhydrous compound and is not broken down into adenosine in the synaptic cleft like  ATP.  
Therefore, we can assume that the down-regulation of the GABA receptor is caused by the 
activation of the P2X receptors rather than the A1 adenosine receptors.  The effect of the 
purinergic modulation of the GABA receptors was greater under conditions where the 
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intracellular calcium concentration was not clamped (0.2 mM EGTA), parallel to observations 
previously reported by Sokolova et al. (2001).  When 0.2 mM EGTA was used in the 
intracellular solution, the response to GABA (100 µM) recorded immediately after the 
application of 10 µM ATP was reduced to 67 ± 20% (n=7) of the control; this effect was 
statistically significant with a confidence level of P=0.02 (one-population t-test).  In similar 
conditions, application of 10 µM α,β-meATP inhibited GABA-activated currents to 69 ± 27% 
(n=5) of control (Fig.3.1:10).  The significance level for this effect was P=0.02 (one-population 
t-test).  Interestingly, there is no statistically significant difference between α,β-meATP and ATP 
in 0.2 mM EGTA concentrations (verified by two-population t-test) despite their effects being 
significantly different separately. 
On the contrary, when high EGTA concentrations (10 mM) were used in the intracellular 
medium, activation of the P2X receptors did not cause inhibition of the GABA receptors.  The 
GABA response recorded after the application of ATP was slightly potentiated to 110 ± 69% 
(n=11) of control and application of α,β-meATP prevented the P2X mediated inhibition of 
GABAA-mediated currents, 100 ± 5% (n=6).  Comparison of the action of α,β-meATP in the 
presence of 0.2 mM EGTA and 10 mM EGTA (Fig.3.1:11) revealed that difference in the effects 
were statistically significant (P=0.005, two-population t-test).   
 The two predominant P2X receptor subtypes expressed on DRG neurons are homomeric 
P2X3 and heteromeric P2X2/3 receptors (Cook et al., 1997; Vulchanova et al., 1997) which 
exhibit both fast and slow kinetically distinct responses.  Our results highlight the role of both 
receptor subtypes in the P2X receptor driven down-regulation of GABAA receptors expressed on 
DRG neurons, but this effect is limited to 0.2 mM EGTA concentrations only.  Hence, our results 
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underline the crucial role that Ca
2+ 
signalling plays in this interaction between P2X and GABAA 
receptors in DRG neurons. 
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Figure 3.1:10. The effect α,β-meATP on GABAA receptor-mediated responses elicited from DRG 
neurons in low and high Ca
2+
 concentrations. 
Recorded GABAA receptor mediated currents before (left) and after (right) P2X receptor activation in both 
0.2 mM and 10 mM EGTA concentrations on dorsal root ganglion neurons.  P2X receptors are able to 
down-regulate GABAA receptor-mediated currents in low EGTA concentrations only, highlighting the Ca
2+
 
dependence of this receptor interaction.  Currents were recorded in different cells at a holding potential of -
80 mV.  
α β  
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Figure 3.1:11.  A comparison of the significance of the effect of ATP and α,β-meATP in 0.2 mM and 
10 mM EGTA concentrations on GABAA receptor-mediated currents expressed on DRG neurons in 
the peripheral nervous system.   
In 0.2 mM EGTA concentrations the evoked GABA current immediately after the application of both 
ATP and α,β-meATP were inhibited.  However, in 10 mM EGTA concentrations there was no down-
regulation of the GABAA receptor-mediated currents, indicating the significance of calcium in this 
receptor interaction.  The impact of α,β-meATP and ATP of GABA on currents was statistically 
significant with a confidence level of P=0.005 (one population t-test).  Despite both affects of the P2X 
agonists being statistically significant separately they failed to show any significance when their affects 
were compared together in 0.2 mM EGTA concentrations (two population t-test). 
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3.2 P2X and GABAA receptor interactions are strongly dependent on calcium influx 
through the purinergic receptors 
 
3.2.1. Variability in the control GABA responses 
 In the earlier stages of experiments we observed a marked variability (up-to 50%) of the 
amplitude of GABAA-activated currents in the control phase of the protocol; often there was a 
significant run-down of subsequent responses to GABA (Fig. 3.2.1:12).  When 0.2 mM EGTA 
was used in the intracellular solution, the average amplitude of the initial response to the 
application of 100 μM GABA was 135 ± 43 pA, whereas the average amplitude of the second 
control response was 76 ± 31 pA (n=34).  Conversely, with 10 mM of intracellular EGTA the 
initial GABA receptor-mediated response was 258 ± 74 pA and the subsequent response reached 
267 pA ± 79 (n=35).  On the third or fourth GABA application the recorded responses appeared 
to stabilise. The time interval between the each of the responses was 3 minutes.  It should be 
emphasized that no ATP or α,β-meATP had been applied to cause such an effect as these 
responses were recorded before the application of the P2X receptor agonist.  This occlusion 
could not be attributable to the desensitisation kinetics of GABAA receptors as sufficient time 
was left between each application (3 minutes) to omit cumulative agonist-provoked 
desensitisation (Chen et al., 1990). 
In all of our experiments it was noted that this initial GABA rundown happened only 
when the intracellular solution containing 0.2 mM of Ca
2+
-chelator was used.  The variability of 
control GABAA receptor mediated currents was much less (5-10%) when the concentration of 
intracellular Ca
2+
-ions was kept at physiological baseline level of 50-100 nM by using 10 mM 
EGTA (Egelman and Montague, 1999).  Furthermore, it was noted that the amplitude of GABAA 
responses usually underwent significant changes when we recorded the response of the cell to a 
  
65 
 
voltage step from -80 to -20 mV between applications of GABA.  This voltage-step was 
routinely used for monitoring the cell viability and conditions of voltage-clamp.  The response to 
the voltage-step comprised of currents mediated by voltage gated Na
+
- and Ca
2+
-channels.  
Research suggests that GABAA receptors can be dephosphorylated via a Ca
2+
/calmodulin 
dependent phosphatase (Chen et al., 1990; Chen et al., 1995) and phosphorylated by CaMKII and 
PKC (Houston et al., 2008;Houston et al., 2009; Brandon et al., 2000) rendering the receptor 
non-functional. However, the mechanisms underlying this phenomenon are not completely 
understood.  Hence, to provide more stable conditions for control responses to GABA, another 
voltage step protocol (-80 to -70 mV) was introduced to monitor the cells between drug 
applications. This protocol did not activate the Ca
2+
-channels and consequently the GABA 
control response variability was reduced to 10-20%.   
 The run-down of GABA-activated currents in the presence of low concentrations of 
intracellular Ca
2+
-chelator could not be avoided completely.  There was a significant drop in the 
amplitude of response to the second application of GABA (Fig. 3.2.1:12a) followed by a slow 
decline in consecutive responses. To minimize the influence of this run-down on our results, we 
recorded at least three to four control responses to GABA before applying P2X receptor agonists. 
To estimate the effect of the P2X receptors, the amplitude of GABA receptor-mediated currents 
was normalized to the average amplitude of several control GABA-currents recorded before (2 
responses minimum) and after (1-3 responses) the application of the P2X receptor agonist.  This 
protocol allowed for the compensation of the variability in GABA-activated currents, which 
could potentially give a lower estimate for the effect produced by the P2X agonists.  Therefore, 
our results produce a more conservative estimate on the interaction between P2X and GABA 
receptors. 
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Figure 3.2.1:12. Variability in the initial control GABAA mediated currents in low and high EGTA 
concentrations. 
 
A, shows the initial receptor mediated responses on the application of GABA (100 µM) before P2X 
agonist application in low Ca
2+
 chelator concentrations (0.2 mM EGTA).  There is a significant level of 
rundown between the first and second responses, but the second and third responses are relatively of the 
same amplitude.  There was virtually no variability in the initial GABA receptor responses in 10 mM 
EGTA (B).  
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Figure 3.2.1:13. A comparison of the average amplitude of the first and second control GABA 
responses in 10 mM and 0.2 mM EGTA concentrations. 
 
The stability of the GABA mediated control currents is greater in 10 mM EGTA when compared to the 
0.2 mM EGTA intracellular concentrations.  Currents were recorded in different cells at a holding 
potential of -80 mV. 
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3.2.2  Examining the role of voltage-gated calcium channels in the receptor interaction   
To test the hypothesis that it is strictly Ca
2+
-influx through P2X receptors which down-
regulates GABAA receptors, we used an experimental protocol where by Ca
2+
-entry was 
provided by voltage-gated calcium channels (Fig. 3.2.2:14) instead of activating the P2X 
receptors using ATP.  Rather unexpectedly, this protocol did not reproduce the effect of the P2X 
receptor agonists.  We observed not only the inhibition but also the rebound potentiation of 
GABAA mediated currents in 30% of cells tested.  This large potentiation indicates a prolonged 
increase in the sensitivity of the activated GABAA receptors to it’s agonist.  The extent of the 
potentiation varied from 20 to 200% when compared to the control responses.   
  Inhibition of the GABAA receptor mediated responses was much smaller than one could 
expect from such a large Ca
2+
-influx through the voltage-gated Ca
2+
-channels.  The GABA 
response recorded after the stimulation of the Ca
2+
-channels was inhibited just to 80-90% of 
control; in the fraction of cells tested there was no inhibition at all.  The magnitude of the 
inhibition caused by the activation of the voltage-gated Ca
2+
-channels (Fig. 3.2.2:14) is 
comparitively smaller than the magnitude of the GABAA receptor inhibition caused by Ca
2+
 
influx through activated P2X receptors (Fig. 3.1:10).  
 These observations suggest that not only Ca
2+
-influx, but also activation of the P2X 
receptors themselves is essential for the inhibition of GABAA receptors.  We observed neither 
potentiation nor inhibition of the GABAA response by Ca
2+
-channels with 10 mM EGTA in the 
intracellular medium.  This implies that the level of intracellular calcium is still important for 
both the up- and down-regulation of the GABAA receptors.   
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Figure 3.2.2:14.  The effect of voltage-gated Ca
2+
 channels activated by a -80 to -20 mV voltage-step.  
Note that inhibition of the GABA-current was followed by rebound potentiation in 30% of cells tested.  
The level of inhibition observed during the experiments was much smaller than one could expect from 
such a large calcium influx through the voltage-gated calcium channels.  In fact some of the cells tested 
showed no inhibition of the GABA evoked currents.  This suggests that activation of the P2X receptors as 
well as calcium influx through the purinergic receptor channel is vital to the receptor interaction.  
Currents were recorded with 0.2 mM EGTA in the intracellular medium. 
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3.3 The effect of the intracellular modulation of GABAA receptors on the P2X driven 
inhibition of GABA currents 
 Since there is no effect on GABAA receptor mediated currents upon the activation of the 
P2X receptors in 10 mM EGTA concentrations this suggests that Ca
2+
 influx via P2X receptors 
is essential to this receptor interaction.  It is widely acknowledged that GABAA receptors can 
undergo Ca
2+
-dependent modulation by phosphorylation (Kittler and Moss, 2003). This 
modulation could provide a basis for the interaction between P2X and GABAA receptors.   
To study the effects of phosphorylation of the GABAA receptor on this mechanism we 
applied both Cyclosporine A and Staurosporine to the cells.  Blocking Phosphatase II did not 
alter the inhibition of the GABAA current 62 ± 17% (n=7), but blocking PKC (98 ± 13% n=7) 
and CamKII (97 ± 13% (n=5) almost completely abolished the P2X driven inhibition of GABAA 
evoked responses (Fig. 3.3:15).  The action of Staurosporine and KN93 when compared to the 
action of ATP in control conditions was statistically significant with a confidence level of 
P=0.02 (two population t-test).  Thus, the results suggest that the functional linkage between the 
P2X and GABA receptor responses is via modulation by a Ca
2+
-dependent phosphorylation 
process, rather than direct coupling between the receptors as previously reported (Toulme et al., 
2007; Boue-Grabot et al., 2004 ; Jo et al., 2011). 
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3.4 Interim conclusions on the P2X receptor driven down-regulation of GABA receptor-
mediated currents in the peripheral nervous system  
Figure 3.3:15. The effect of Staurosporine and Cylosporine A on P2X receptor mediated inhibition of 
GABAA evoked currents in DRG neurons. 
A, GABA receptor-mediated responses recorded in high and low EGTA concentrations and under the 
influence of phosphatase and kinase blockers.  B, Blocking Phosphatase II using Cyclosporine A had no effect 
on the impact of P2X receptors on GABAA mediated currents as a similar level of inhibition was observed in 
control conditions.  Blocking PKC and CaMKII almost completely eliminated this effect, suggesting that 
phosphorylation is vital to this mechanism.  The action of Staurosporine and KN93 was statistically significant 
with a confidence level of P=0.02 (two population t-test).  All experiments involving phosphatase and kinase 
inhibitors were carried out using 0.2 mM EGTA in the intracellular medium.  
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  One of the most principal pathways of ATP action as a neurotransmitter can be the 
direct calcium dependent modulation of neighbouring receptors expressed on the post synaptic 
membrane, such as NMDA (Pankratov et al., 2002a) and GABA receptors.  Our results show 
that ATP is able to down-regulate GABAA receptor function in the peripheral nervous system; 
however excitatory ATP fast neurotransmission has also been demonstrated in the CNS 
(Pankratov et al., 1998).  Its exact role in modulating synaptic transmission is not yet clarified.   
Research has shown that P2X receptors can localise at inhibitory GABAergic synapses in 
the CNS (Lalo et al., 2006).  The co-localisation of P2X with other receptors could be crucial to 
their modulatory actions on other membrane proteins expressed on the postsynaptic membrane.  
The influx of Ca
2+
 through P2X receptors may cause the activation of secondary messenger 
signalling cascades to cause the up or down-regulation of the co-localised receptors.  Since 
GABA dysfunction in the central nervous system has been implicated in many neurological 
disorders such as schizophrenia and epilepsy it is important to also configure the impact of 
purinergic modulation on GABAA receptors expressed in the CNS as the next series of results 
will highlight. 
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3.4 The P2X receptor driven down-regulation GABAA receptors on acutely isolated L2/3 
neo-cortical pyramidal neurons 
 Activated P2X receptors were also able to occlude GABAA receptor mediated currents in 
acutely isolated L2/3 neocortical pyramidal neurons via a similar mechanism that we previously 
observed in DRG neurons of the peripheral nervous system (ref. Fig. 3.1:10).  In low calcium 
chelator concentrations (0.2 mM EGTA) GABA receptor responses recorded after the 
application of the P2X receptor agonist were reduced to 58 ± 11% (n=23) and 60 ± 18% (n=16) 
of control after ATP and α,β-meATP application respectively (Fig. 3.5:16).  Both effects were 
statistically significant with confidence level P=0.005 (one-population t-test).  However, 
comparison of the action of ATP and α,β-meATP on GABA receptor-mediated responses 
revealed that their effects are not significantly different.  No effect of P2X receptors on GABA 
receptor evoked currents was observed in 10 mM EGTA concentrations on the application of 
ATP or α,β-meATP (Fig. 3.5:17).   
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Figure 3.4:16. A comparison of the effect of ATP and P2X receptor specific agonist α,β-meATP on 
GABAA receptor evoked responses elicited from acutely isolated L2/3 pyramidal neurons in 10 mM 
and 0.2 mM EGTA concentrations.    
A, in 0.2 mM EGTA concentrations the application of ATP inhibited the receptor mediated currents 
of GABAA receptors expressed on neocortical pyramidal neurons.  However, P2X receptor activation 
with 10 mM EGTA concentrations in the intracellular medium failed to suppress the GABA currents.  B, 
Similarly, the application of α,β-meATP caused the down regulation of GABA mediated currents in 0.2 
mM EGTA concentrations but not in 10 mM EGTA. The down regulation of GABA evoked currents 
were statistically significant with a level of confidence of P=0.005 when both P2X receptor agonists 
were applied in separate experiments.  The results highlight the calcium dependence of the receptor 
interaction in the central nervous system, parallel to previous results obtained in the peripheral nervous 
system.  
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Figure 3.4:17. The effect of α,β-meATP on GABAA evoked responses elicited from acutely isolated 
L2/3 pyramidal neurons is mediated by Ca
2+
.  
A, shows receptor mediated responses activated by the application of GABA (100 μM) before and after 
the application of α,β-meATP (10 μM) in 0.2 mM EGTA concentrations.  Activated P2X receptors are 
able to inhibit GABAA receptor mediated currents in low EGTA concentrations expressed on central 
neurons. B, the amplitude of GABA responses before and after the introduction of ATP in high calcium 
chelator concentrations (10 mM EGTA) reveals the failure of α,β-meATP to inhibit GABAA responses.  
Currents were recorded in different cells at a holding potential of -80 mV.  The figure was taken from 
(Lalo et al., 2009).  
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3.5 PKC plays a significant role in the P2X driven modulation of GABAA receptors in the 
central nervous system 
Previously we have shown that GABAA receptors are targets of modulation by 
intracellular signalling cascades involving Ca
2+
-dependent phosphorylation in the peripheral 
nervous system (Fig. 3.3:15).  Since P2X receptors are also able to down-regulate GABAA 
receptors expressed on cortical neurons via a Ca
2+
-dependent mechanism (Lalo et al., 2009), we 
then went on to look at the impact of GABAA receptor phosphorylation on this mechanism in the 
central nervous system. 
Application of blockers of cAMP-dependent kinase, PKA, failed to eliminate the P2X 
receptor-mediated inhibition of currents elicited from GABAA receptors on cortical neurons.  
GABA responses recorded after the application of ATP under the influence of H-89 and KT5720 
were still inhibited 67 ± 23% (n=26) of control and 49 ± 16% (n=5) accordingly.  Our results 
indicate that PKA is not involved in the down regulation of GABA evoked currents by P2X 
receptors.  
GABA receptors have a conserved Protein Kinase C (PKC) binding domain located on 
their β subunit (Brandon et al., 2000; Brandon et al., 2002; Kittler et al., 2003) and it is 
established that PKC is able to modulate the function of GABAA receptor mediated responses in 
cultured hippocampal and cortical neurons (Connolly et al., 1999).  To study the involvement of 
PKC in this mechanism we applied 5 nM of Staurosporine to the cells and recorded responses to 
GABAA before and after the application of P2X receptor agonist, ATP (Fig. 3.6:18).  In this 
instance Staurosporine was able to completely block the purinergic modulation of GABAA 
receptors by 101 ± 10% (n=4).  
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Staurosporine is marketed as a broad spectrum kinase inhibitor with an IC50 of ~7 nM for 
PKA and an IC50 of ~3 nM for PKC (Tamaoki et al., 1986).  At a concentration of 5 nM it is 
highly probable that we were partially blocking both kinases with preference to PKC.  As such 
we then went to reconfirm our results by applying a more specific blocker of PKC, GF109203X 
(Fig. 3.2.1:18). The GABAA receptor-mediated response recorded immediately after the 
activation of the P2X receptors resulted in the almost complete abolishment of GABAA 
inhibition by 92 ± 13% (n=6).  To further establish the involvement of PKC, sub-threshold 
concentrations of both Staurosporine and GF109203x were applied simultaneously.  
Consequently, introducing both kinase inhibitors to the cells produced a slight potentiation of the 
GABAA mediated responses and no inhibition (105 ± 9% n=7).  A comparison of the action of 
ATP in control conditions and under the influence of inhibitors of PKC revealed that the 
difference in the effects were statistically significant with a confidence level of P=0.02 (two 
population t-test).  Therefore, our results strongly suggest a potential role for PKC in the 
interaction between these two ionotrophic receptors.  
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Figure 3.5:18: PKC is able to completely abolish the P2X receptor-mediated down-regulation of 
GABAA  receptor currents in isolated cortical neurons. 
A, the blocking of PKA has no effect on the ability of activated P2X receptors to inhibit GABAA receptor 
evoked currents. However, blocking PKC with Staurosporine, GF109203x and then a combined application 
of both kinase inhibitors almost or completely blocked the purinergic modulation of GABAA receptors.  B, 
comparison of the action of ATP in control conditions and under Staurosporine and GF109203x revealed 
that the difference in the effects were statistically significant with a confidence level of P=0.02 (two 
population t-test).  All experiments in which kinase inhibitors were washed on to the cells 0.2 mM EGTA 
concentrations were used unless otherwise stated.  
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3.6 Discussion  
The presence of fast excitatory purinergic synaptic transmission has only been 
demonstrated in a number of regions in the central nervous system: the spinal cord (Jo and 
Schilchter, 19993), locus coeruleus (Nieber et al., 1997), hippocampus (Pankratov et al., 1998) 
and many more (Hugel et al., 2000).  Research has shown that P2X subunit expression occurs on 
both the soma and dendrites of pre- and postsynaptic cells in the CNS (Vulchanova et al., 1997; 
Kanjhan et al., 1999), which highlights the potential of P2X receptors to modulate the function of 
other receptors at synapses in the brain via pre- and postsynaptic processes.  P2X receptors are 
major contributors to nociceptive pain signalling in the spinal cord (Burnstock, 2000) and thus 
have become the focus of intense pharmacological research.  Therefore, it is important to 
elucidate the function of ATP signalling in the central nervous system and the impact that the 
action of ATP can have on brain function. 
 To examine this paradigm we observed the postsynaptic actions of P2X on GABAA 
receptor mediated currents as it has been previously reported that P2X receptors can modulate 
inhibitory GABAA currents on DRG neurons and Xenopus oocytes (Sokolova et al., 2001; 
Toulme et al., 2007).  We studied the P2X driven down-regulation of GABAA receptor mediated 
transmembrane currents in both the peripheral and central nervous system, where the underlying 
mechanism is strongly dependent on intracellular Ca
2+ 
concentrations.  This is demonstrated 
continuously throughout our experiments as ATP and it’s non-hydrolysable analogue α,β-
meATP only had an effect on GABAA mediated responses in 0.2 mM EGTA and not 10 mM 
EGTA where the intracellular Ca
2+ 
concentration is kept at physiological baseline levels. 
Additionally, the control GABA responses are significantly variable in 0.2 mM EGTA solutions, 
emphasising the potential calcium dependence of this interaction.  Therefore, our findings 
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contradict previous experimental data which disputes the necessity of Ca
2+
 in this receptor 
interaction (Toulme et al., 2007).   
There are many P2X receptor isoforms expressed in the peripheral and central nervous 
systems, evoking a wide range of kinetically distinct P2X receptor phenotypes.  Whilst 
conducting our experiments we observed different phenotypes of currents elicited from activated 
P2X receptors (fast, slow and mixed responses), suggesting the possibility that the amount of 
calcium influx through the receptor channel is variable and dependent on the kinetics of the P2X 
receptor subtype.  Since we observed the occlusion of GABA mediated currents regardless of the 
type of P2X receptor activated in both the peripheral and central nervous systems reinforces the 
idea that purinergic modulation of GABAA receptors is a universal phenomenon.   
The purinergic modulation of GABAA receptors is not solely attributable to Ca
2+
 influx 
through the P2X receptors as the state of the GABAA receptors themselves may play a significant 
role in respect of their subunit composition and phosphorylation state.  Observations have 
demonstrated that GABAA receptors harbour a series of highly conserved phosphorylation sites 
specifically on their β- and γ-subunits (Brandon et al., 2000; Vithlani et al., 2011).  As 
phosoproteins GABAA receptors are prone to intracellular modulation via a Ca
2+
-dependent 
phosphorylation process (Brandon et al., 2002; Kittler et al., 2003; Kumar et al., 2005; Houston 
et al., 2009).  We have studied the impact of GABAA phosphorylation on the receptor 
interaction.  Our results show that by inhibiting PKC the action of P2X receptors on GABAA 
mediated currents is completely abolished and these experiments were performed in low 
concentrations of Ca
2+
 chelator (0.2 mM EGTA).
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Emphasis is put on the role of Ca
2+
 in the inhibition of GABAA receptors as we observed 
a significant difference between the average of the first and second GABAA receptor control 
responses.  This effect is restricted to 0.2 mM EGTA concentrations only (Fig. 3.2.1:11a), which 
further implicates Ca
2+ 
in the down-regulation of GABAA evoked responses in the peripheral and 
central nervous systems.  Research has demonstrated that the stability of GABAA receptors is 
mediated by clatharin-dependent endocytosis and involves PKC (Connolly et al., 1999; Kittler et 
al., 2003; Arancibia-Cárcamo et al., 2009).  Therefore, the P2X receptor driven inhibition of 
GABAA receptor function may also be attributable to GABA receptor trafficking via a Ca
2+
-
dependent and an intracellular signalling cascade.   
 By activating voltage gated Na
+
- and Ca
2+
 channels using a voltage step of -80 to -20 mV 
between several GABA applications we have established that Ca
2+
 channels have a small effect 
on GABA responses (Fig. 3.2.2:14).  For instance, the GABA response recorded directly after 
the voltage-step stimulation is smaller when compared to the two control responses.  However, 
their mechanism of action is not similar to the rundown in GABAA mediated currents.  In fact 
what we observed is the rebound potentiation of the GABA response.   
Rebound potentiation has been documented in cerebellar Purkinje neurons where 
excitatory currents were able to prolong inhibitory GABA receptor activation (Kano et al., 1992).  
This mechanism is stimulated by a transient increase in intracellular Ca
2+ 
levels, caused by the 
activation of voltage-gated channels (Kano et al., 1996) which activate protein kinases.  Since we 
have demonstrated the involvement of PKC in the functional modulation of GABAA receptors it 
may be possible that it also plays a crucial role in the rebound potentiation at inhibitory synapses.  
This experimental data concerning the effect of voltage-gated Ca
2+
 channels is preliminary and 
requires more vigorous experimental analysis to specifically determine this mechanism.  
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Nevertheless, this extended GABA receptor signalling, which enhances the efficacy of synaptic 
inhibition may have important implications for learning and memory (Brandon et al., 2002).  . 
 In conclusion, so far we have demonstrated that P2X receptors are able to modulate 
GABAA receptors expressed on the post synaptic membrane via a Ca
2+ 
dependent mechanism.  
The phosphorylation and function of GABAA receptors can be regulated by PKC in cortical 
pyramidal neurons.  Therefore, P2X receptors may dynamically modulate other postsynaptic 
receptors by directly activating Ca
2+ 
dependent signalling cascades in the central nervous system. 
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Chapter 4 
 
The inhibition of GABAA receptors which 
mediate tonic inhibition by P2X 
receptors in the central nervous system 
 
4.0 Introduction 
 The fast inhibitory synaptic transmission in the central nervous system is principally 
derived from the synaptic release of γ-aminobutyric acid (GABA), which activates postsynaptic 
GABAA receptors.  GABAA receptors modulate excitatory synaptic transmission by either 
hyperpolarizing the cell membrane or by shunting excitatory inputs (Yamada et al., 2007).    
 It is widely acknowledged that there are two types of GABAA current which exists in the 
central nervous system: type 1 and type 2.  The type 1 current is produced by GABA receptors 
that are located in the synaptic cleft and activated by high transient concentrations of GABA 
released from the presynaptic terminal.  The type 2 receptor-mediated currents are produced by 
GABAA receptors which are highly sensitive and require a much lower concentration of GABA 
for receptor activation.  In subsequent chapters we will be referring to the type 1 receptor as 
phasic GABAA receptors and type 2 receptors as tonic GABAA receptors. 
 Only recently has the function of phasic GABAA receptors and tonic GABAA receptors 
which reside outside of the synaptic cleft been integrated (Wall and Usowicz, 1997; Nusser et al., 
1998; Semyanov et al., 2004).  The spill over of GABA from the synapse innervates tonic 
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GABAA receptors to produce a prolonged GABA tone termed, tonic inhibition.  Conventionally, 
functional phasic receptors consist of α, β and γ subunits, however tonically activated GABA 
receptors are composed of a distinct set of highly sensitive subunits, including α5- and δ-subunits 
in the central nervous system.     
 Whilst studying the impact of P2X receptors on neurotransmission in both the peripheral 
and central nervous systems we have demonstrated the down regulation of phasic GABAA 
receptor-mediated currents as a result of being targets of purinergic modulation.  P2X receptors 
are able to inhibit GABA responses this way as a result of their high Ca
2+
 permeability which 
engenders the activation of an intracellular signalling cascade.  The application of kinase 
inhibitors to the recording chamber resulted in the removal of the inhibition of GABA receptor- 
mediated responses, particularly in the presence of blockers of Protein Kinase C.  Therefore, we 
surmise that this receptor interaction is Ca
2+
-dependent and also involves the regulation of 
GABAA receptors by PKC phosphorylation.  
 Dysfunctional GABAA receptors that mediate tonic inhibition in the central nervous system 
have been implicated in many neurological disorders (Jacob et al., 2008).  Extrasynaptic tonic 
GABAA receptors are prime targets for various reagents (Cheng et al., 2006; Santhakumar et al., 
2007) it is highly possible that they could act as novel therapeutic targets for a plethora of 
neurological pathophysiologies.  Although it has been suggested that tonic inhibition occurs on 
neocortical pyramidal neurons (Salin et al., 1996) the underlying mechanism and the 
physiological relevance of this phenomenon is far from being elucidated, and thus they became a 
key focus in this project.   
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4.1 Pharmacologically isolating subunit specific GABAA receptors mediating tonic 
inhibition 
 Tonic conducting GABAA receptors are localised outside the boundaries of the synaptic 
cleft and they are transiently activated via a spill over of neurotransmitter from the synapse.  The 
tonically active current is caused by a specific subset of GABAA receptor subunits that are highly 
sensitive and have slower desensitizing kinetics, consisting primarily α1, α5, α4 and δ subunits 
(Nusser et al., 1998; Mortensen and Smart, 2006; Glykys and Mody, 2008; Olsen and Sieghart, 
2009).  δ-GABAA receptor subunits are restricted to extrasynaptic locations (Nusser et al., 1998) 
and studies have demonstrated their expression in the somatosensory neocortex (Yamada et al., 
2007).    
 To confirm that we were selectively activating tonic rather than phasic GABAA receptors, 
receptor mediated responses were measured from acutely isolated pyramidal neurons.  Due to the 
differentiation of GABA sensitivities conferred by the different subunit compositions of the 
receptors we applied various concentrations of GABA to the cells, ranging from 0.1 µM to 200 
µM to produce a dose response curve.   
 The broad spectrum of GABA concentrations applied were (in µM) 0.1, 0.2, 0.5, 1, 5, 10, 
20, 100 and 200 (Fig 4.1:19).  From the dose-response curve it can be deduced that tonic 
GABAA receptors have an EC50 of 0.89 µM which is in accordance with previous data (Brown et 
al., 2002; Borghese et al., 2006).  Even at concentrations below this value we still observed 
activation of the tonically active receptors, which emphasises the high sensitivity of 
extrasynaptic GABAA receptors to ambient GABA concentrations.    
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Figure 4.1:19.  GABAA receptor sensitivity of neocortical pyramidal neurons 
A dose-response curve showing the relationship between varying concentrations of GABA and the peak 
activated receptor currents.  From the GABA concentration-dose response curve it is evident that two 
populations of GABA receptors are present.  We observed responses mediated by the high affinity GABA 
receptors at the lower agonist concentrations (0.1-5 µM) and responses mediated by receptors with a 
lower affinity at the higher concentrations of GABA (10-200 µM).  All of the responses were normalised 
on the GABA current which was generated by a saturating concentration of agonist during the 
experiments.  We observed receptor saturation at 200 µM of GABA.  The data was accumulated from 
individual acutely isolated pyramidal neurons of the neocortex. All recordings were conducted using 0.2 
mM EGTA in the intracellular solution at a holding potential of -80 mV.   
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4.2 δ-subunit GABAA containing receptors mediate tonic inhibition in the somatosensory 
cortex 
 The expression of the GABA δ-subunit has been previously recognised in the 
somatosensory cortex (Yamada et al., 2007) and they are major contributors to the tonic 
conductance in this brain region.  To study the subunit specificity for phasic and tonic GABAA 
receptors we introduced DS2, a novel positive allosteric modulator of the δ-subunit containing 
receptors (Wafford et al., 2009) to the extracellular solution whilst conducting experiments.   
 Under control conditions we observed a mean amplitude in the range of 50-250 pA (n=12) 
in response to the application of 0.2 µM of GABA.  After introducing DS2 (300 nM) into the 
extracellular medium concurrently with the fast application of 0.2 µM of GABA the mean 
activated receptor response was considerably potentiated ranging from 100-400 pA (n=7) (Fig. 
4.2:20).  The average increase of DS2 influenced GABAA receptor mediated responses was 95% 
± 67% n=7 when compared to control conditions.  The effect of DS2 on activated GABAA 
receptor currents was statistically significant at a confidence level of P=0.01 (one-population t-
test).  Our results confirm the expression of δ-subunits on neocortical pyramidal cells and thus 
this specific extrasynaptic GABA receptor subtype is major contributor and accountable for 
mediating tonic inhibition in the somatosensory cortex.   
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Figure 4.2:20.  The pharmacological isolation of δ-subunit containing GABAA receptors that 
mediate tonic inhibition in cortical pyramidal neurons. 
In control conditions (left) 200 nM of GABA applied to the recording chamber produced a mean response 
in the range of 50-250 pA (n=12).  However, this response was significantly potentiated under the 
influence of a novel allosteric modulator of the δ-GABAA receptor subunits, DS2 (right), ranging from 
100-400 pA (n=7).  δ-subunit containing GABAA receptors are located extrasynaptically and have been 
demonstrated to have a major role in conducting tonic currents in the somatosensory cortex (Yamada et 
al., 2005).  All experiments were carried out in 0.2 mM EGTA.  Currents were recorded at a holding 
potential of -80 mV.  
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4.3 GABAA receptors mediating tonic inhibition are targets of purinergic modulation 
 Due to our previous results obtained when studying the sensitivity of extrasynaptic GABAA 
receptors to their agonist (Fig. 4.1:19) we applied 1 µM of GABA to acutely isolated pyramidal 
neurons before and after the introduction of the P2X specific agonist, α,β-meATP (10 µM).  As 
previously observed with phasic GABAA receptors, our results demonstrate that extrasynaptic 
GABAA receptors are also inhibited by P2X receptor activation.  Tonic GABAA receptor 
responses were reduced to 66 ± 16% n=19 of control in low EGTA concentrations (Fig. 4.3:21).   
However, in 10 mM EGTA, no inhibition mediated by α,β-meATP application was observed, 96 
± 8% n=11.  We used non-anhydrous ATP analogue α,β-meATP to eliminate the possible effects 
of adenosine when ATP is broken down in the synaptic cleft.  Individually, both of these effects 
were statistically significant with a confidence level of P=0.005 (one-population t-test).  
 We also studied the action of ATP on the P2X receptor driven down-regulation of tonic 
GABAA receptors (Fig. 4.3:22).  Fast application of ATP to the recording chamber caused the 
inhibition of the tonic receptors recorded immediately after the activation of the ATP receptor in 
low EGTA concentrations, 62 ± 19% n=16.  In 10 mM concentrations of calcium chelator the 
tonic GABAA response was inhibited to a similar level as we observed on application of α,β-
meATP, 92 ± 7% n=11 of control.  Both effects were significant with a confidence level P=0.005 
(one population t-test).   Hence, tonically activated GABAA receptors are also prime targets of 
the modulatory actions of purinergic receptors.   
 We observed inhibition of both phasic and tonic GABAA receptors in the central nervous 
system and of phasic receptors on DRG neurons in the peripheral nervous system.  Inhibition 
was caused by the activation of P2X receptors with both ATP and α,β-meATP, which have 
specificity for different P2X isoforms.  Therefore, our results highlight the universal nature of 
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this mechanism and the possible expanse of the modulatory repertoire of purinergic receptors on 
the postsynaptic membrane in the central nervous system.   
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Figure 4.3:21.  Tonically active GABAA receptors are also targets of purinergic modulation  
Activated P2X receptors are able to inhibit GABAA receptors that reside beyond the boundaries of the 
synaptic cleft expressed on isolated cortical pyramidal neurons in 0.2 mM EGTA concentrations.  As seen 
previously with phasic GABAA receptors there was a significant level of inhibition of the tonic GABA 
receptor mediated currents after the activation of the P2X receptor.  Since no effect of the P2X receptor 
agonist application was observed in 10 mM EGTA concentrations, indicating a definite role of calcium in 
this mechanism.  All recordings were conducted with a holding potential of -80mV 
0.2 mM EGTAIN 
10 mM EGTAIN 
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Figure 4.3:22.  A comparison if the impact of the application of P2X receptor agonists ATP and α,β-
meATP on tonically activated GABAA receptors.  
The down-regulation of tonically active GABAA receptors by purinergic modulation in the neocortex is a 
calcium dependent process. A, in 0.2 mM EGTA there is a considerable reduction in the average 
amplitude of the GABAA response recorded immediately after the application of the P2X agonist ATP, 
but this effect was absent in 10 mM EGTA concentrations B, when α,β-meATP was applied to the 
isolated neurons there was also a significant decrease in the GABA receptor response in 0.2 mM EGTA 
concentrations only.   
α,β-meATP 
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4.4 Purinergic modulation of extrasynaptic GABAA receptors is mediated by protein 
kinases 
 Previously we have revealed that GABAA receptors of the peripheral nervous system are 
modulated by a Ca
2+
-dependent intracellular signalling cascade as are the phasic GABAA 
receptor-mediated currents in the central nervous system.  To examine the possible effects of 
intracellular modulation on tonically active receptors we followed the same protocol that we 
utilised when studying the impact of phosphorylation on synaptic GABAA receptors (ref. 
Chapter 3, Fig. 3.6:18).   
  Tonically active GABAA receptor responses recorded immediately after activation of the 
P2X receptors were inhibited in low EGTA concentrations (Fig. 4.3:21).   However, this effect 
was absent when the same protocol was performed using a high concentration of EGTA (10 mM 
EGTA) in the intracellular medium as no inhibition was observed.  When 0.2 mM EGTA was 
introduced to the patch pipette alongside the application of PKC blocker, GF109203x, the 
purinergic induced inhibition of tonic GABA receptor responses was hampered, 95 ± 14% n=9 
of control (Fig. 4.4:23).   Similarly, applying sub-threshold concentrations of GF109203x and 
Staurosporine completely eradicated the purinergic modulation directed at extrasynaptic GABA 
receptors, 102 ± 13% n=7 of control.  Both effects were statistically significant with a confidence 
level of P=0.005 (one-population t-test).  Therefore, the inhibition of tonic conducting GABAA 
receptors is similar to phasic GABAA responses, whereby, the interaction between both GABAA 
receptor subtypes and P2X receptors is Ca
2+
-dependent and potentially modulated by PKC.  
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Figure 4.4:23.  The impact of intracellular modulation of tonically active GABAA receptors and the 
interaction with P2X receptors on cortical pyramidal neurons 
The PKC blocker GF109203x is able to prevent the P2X receptor driven down-regulation of tonically 
activated GABA receptors, parallel to observations made on phasic GABA receptors.  The introduction of 
sub-threshold concentrations of GF109203X and Staurosporine (10nM and 1nM respectively) blocked the 
P2X mediated inhibition to a greater effect than GF109303X alone.  Our results highlight the significant 
role of PKC in the interaction of P2X receptors with GABAA receptors which mediate tonic inhibition in 
the in the central nervous system. 
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4.5 Discussion 
Tonically-activated GABAA receptors expressed on central neurons, containing α5- and 
δ-subunits are also affected by this P2X and GABAA receptor interaction.  We observe when 
there is 0.2 mM EGTA in the intracellular medium of the recording pipette a pronounced 
decrease in the amplitude of the GABA receptor response when GABA is applied immediately 
after the application of the P2X receptor agonist.  This effect of P2X receptor activation is absent 
in high concentrations of calcium chelator (10 mM EGTA).  Therefore the functional linkage 
between the P2X and the tonic GABA receptor activated responses is an influx of calcium 
through the purinergic receptors, equivalent results were obtained with phasic GABAA receptors.  
The influence of P2X receptors on tonically active GABAA receptor currents is also 
similar to their actions on phasic GABAA receptors as our results show that their effect is 
mediated by the activation of an intracellular signalling cascade involving PKC.  Perfusion of 
sub-threshold concentrations of PKC blockers Staurosporine and GF109203x hampered the P2X 
receptor driven inhibition of tonic GABA responses.  Since no effect of P2X receptors was 
demonstrated in high concentrations of calcium chelator and the addition of PKC inhibitors 
eradicated the purinergic modulation of tonic GABA receptors, the results indicate the strong 
dependence of calcium and PKC to this receptor interaction on isolated neocortical neurons.    
Expression of δ-subunits in the somatosensory cortex has been demonstrated (Yamada et 
al., 2007) and our results confirm this finding with the potentiation of GABA mediated responses 
on the application of δ-subunit allosteric modulator DS2.  The ability of P2X receptors to 
modulate phasic GABAA receptors expressed on peripheral and central neurons and their aptitude 
to block tonically active GABAA receptors enforces the idea that this receptor interaction is a 
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global mechanism.  Hence, our findings highlight the significance of P2X receptor modulation 
and their potential impact on neuronal signalling in the central nervous system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
97 
 
Chapter 5 
The underlying mechanisms of P2X and 
GABAA receptor interactions 
 
5.0 Introduction 
Previous experimental evidence studying the reciprocal inhibition between GABAA and 
P2X receptors expressed on dorsal root ganglion neurons demonstrated that the purinergic 
modulation of GABAA receptors is driven by a calcium dependent mechanism in the peripheral 
nervous system (Sokolova et al., 2001).  However, another experimental group suggested that 
this receptor interaction occurs independently of calcium.  They describe an alternative 
mechanism for the receptor interaction that is attributed to the direct coupling of the intracellular 
motifs on both of the receptors (Boue-Grabot et al., 2004).   
The inhibition of GABA-mediated currents upon the activation of the purinergic 
receptors was observed when agonists ATP and respective analogue α,βme-ATP were applied in 
low concentrations of calcium chelator EGTA (0.2 mM).  On the contrary, no marked effect of 
the P2X receptors was measured on GABA mediated currents when a higher EGTA 
concentration was used in the intracellular medium.  Therefore, our results strongly support the 
role of calcium in the ability of P2X receptors to down regulate GABA receptors in the 
somatosensory cortex.  This is further reinforced by the observations of the long term changes in 
GABA receptor evoked responses that can be modified by Ca
2+
 chelators and protein kinases 
(ref. Chapter 3, Figs. 3.3:13 and 3.6:16).  Nevertheless, the underlying mechanisms of this 
receptor interaction have yet to be elucidated.   
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Usage of protein kinase inhibitors could help to explore the possible effects of 
intracellular signalling pathways on the receptor interaction.  However, this approach should be 
used with caution.  Many kinase inhibitors are classed as broad spectrum inhibitors, whereby a 
single blocker can inhibit a diverse range of protein kinases depending on the specific 
concentration that is applied to the cells.  For instance, Staurosporine can inhibit a variety of 
different kinases including both PKA with an IC50 of ~7 nM and PKC with an IC50 of ~3 nM 
(Tamaoki et al., 1986).  Some blockers were reported to inhibit other protein kinases with a 
potency close to their assumed targets (Davies et al., 2000; Lochner and Moolman, 2006).  
Therefore, using just one protein kinase inhibitor to demonstrate the physiological relevance of a 
particular pathway can hardly be seen as reliable.  To minimize the possible impact of non-
specific action of protein kinase blockers, during our experiments we utilized multiple 
compounds that inhibited kinases. This helped discriminate between protein kinases which could 
possibly be involved in the calcium dependent modulation of GABA receptors (ref. Chapter 3, 
Fig. 3.6:16). 
5.1 Activated P2X currents inhibit GABAA receptor-mediated currents on summation 
 Sokolova et al. (2001) previously studied the negative interaction between P2X and 
GABAA receptors expressed on peripheral dorsal root ganglion neurons.  They demonstrated that 
the experimental linear summation during the co-application of both receptor agonists was much 
smaller than their predicted arithmetical response, in conditions where the intracellular calcium 
concentration was not clamped by intracellular calcium chelator.  However, the occlusion was 
removed in low levels of intracellular calcium, highlighting the significant role of calcium in the 
receptor interaction.   
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 To examine the effects of calcium on the summation of the GABA and P2X responses we 
used a modified experimental protocol (Fig. 5.1:23).  We recorded a series of control responses 
to the application of 100 µM GABA to cortical neurons followed by the concurrent activation of 
both receptors.  Subsequent responses to GABA application were also recorded to test a recovery 
of GABA-response after putative attenuation.  Response to ATP alone was recorded at the end of 
the experiment, to avoid a possible long-term effect on the amplitude of GABA receptor-
mediated currents. 
 When low EGTA (0.2 mM) was used in the intracellular solution the amplitude of the 
observed response when both ATP and GABA were co-applied was significantly reduced.  The 
theoretical sum of the individual receptor mediated responses was much larger than the receptor 
mediated response recorded during our experiments.  The effect of summation was 67 ± 8% 
(n=11) of control, which was statistically significant at a confidence level of P=0.02 (one-
population t-test).  Therefore, when implementing the protocol using high EGTA concentrations 
one would expect that the absence of summation demonstrated on the coapplication of GABA 
and ATP in low EGTA concentrations would be abolished. 
  Despite our expectations the addition of a higher concentration of calcium chelator (10 
mM) in the intracellular medium failed to recover the deficit in summation.  The response to the 
coapplication of agonists was much smaller than the predicted sum of both receptor mediated 
responses and summation was inhibited by 87 ± 14% (n=13) of the control.  This effect was 
statistically significant with a confidence level of P = 0.05 (one-population t-test).   
Similarly, when non-anhydrous ATP analogue α,β-meATP was coapplied with GABA 
the total amplitude of the response was comparable to the effect of ATP, 85 ± 9%  n=7 of the 
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predicted sum of both agonists (Fig. 5.1:22b);  this effect was statistically significant with a 
confidence level of P=0.02 (one-population t-test).  In fact the observed summed response is of 
similar amplitude to the control P2X agonist response, suggesting that GABA did not contribute 
to the response as the receptors evoked current was occluded.   
 Introducing H-89 (inhibitor of PKA) to the extracellular solution whilst conducting the 
summation protocol, had no effect on the P2X summation of P2X and phasic GABA receptor-
mediated currents (Fig. 5.1: 22c) (76 ± 13% n=16).  This result was not unexpected as previously 
blockers of PKA were unable to prevent the down regulation of GABA responses by activated 
P2X receptors on DRG and central neurons.   However, considering the potential role of PKC in 
this receptor interaction we would expect PKC blockers to compensate for the deficit in 
summation.  When the PKC inhibitors were applied to the recording chamber they were unable 
to obstruct the impact of ATP on GABA during the summation protocol (69 ± 11% n=7) and 
summation could not be recovered under these conditions.  Both of these effects were 
statistically significant with a confidence level of P=0.02 (verified by one-population t-test).   
We have previously shown that cortical pyramidal neurons receive tonic inhibitory 
currents which are mediated by GABAA receptors located extra-synaptically and mediate tonic 
inhibition (Semyanov et al., 2004; Glykys and Mody, 2007) are also targets of purinergic 
modulation.  The activity of specific subset of GABAA receptors is modulated by calcium 
dependent phosphorylation (Jacob et al. 2008).  Therefore, one would expect to observe a deficit 
in summation on the co-application of ATP and GABA to tonically active receptors too.  To 
validate this hypothesis all of the previous experiments conducted on phasic GABAA receptors 
were repeated on the GABAA receptors that mediate tonic inhibition in the central nervous 
system and identical results were observed (Fig. 5.1:23).   
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The experimental results conducted in the peripheral nervous system and central nervous 
system significantly highlight the role of calcium in the interaction between P2X and GABAA 
receptors, contrary to the involvement of direct coupling between the receptors (Boue-Grabot et 
al., 2004; Toulme et al., 2007; Jo et al., 2011).  Nevertheless the fact that the GABA and ATP 
responses are not additive during the summation experiments suggests that direct interaction 
between the intracellular components of the receptors could also be partially accountable.  
 If direct coupling does not take a part in the underlying mechanism for this receptor 
interaction, then we would not expect a deficit in summation with a high concentration of 
intracellular Ca
2+
-chelator. However, our results show otherwise.  The significant deficit in 
summation was still present in 10 mM EGTA concentrations, suggesting that calcium is not 
entirely responsible.  Nevertheless, the absence in summation is significantly greater in low 
EGTA concentrations as opposed to high EGTA concentrations.  The reduced level of 
summation described under 10 mM EGTA could be caused by a reduction in P2X-mediated 
receptor signalling as a consequence of the direct coupling.  Enhancement in the levels of the 
deficit in summation witnessed in low levels of calcium chelator suggests that calcium dependent 
phosphorylation is more predominant.  Therefore, the most appropriate assumption is that the 
receptor interaction is mediated by two mechanisms: modifications by Ca
2+
 signalling and 
receptor phosphorylation and to some degree direct coupling between the receptors. 
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Figure 5.1:24. Summation experiments conducted on phasic GABAA receptors expressed on cortical 
pyramidal neurons in low and high concentrations of calcium chelator. 
To selectively activate phasic GABAA receptors in the neocortex we applied 100 µM of GABA.  A, In 0.2 
mM EGTA the amplitude of algebraic predicted sum of GABA and ATP responses (red) when both 
agonists were applied together is larger than the amplitude of the observed experimental response (blue). 
The same effect was demonstrated in 10 mM EGTA concentrations, suggesting a role for direct coupling 
in this receptor interaction.  B, both 0.2 mM and 10 mM EGTA concentrations were unable to recover the 
deficit in summation when 10 µM of α,βme-ATP and 100 µM GABA were co-applied, as observed 
previously with ATP under the same conditions.  Note that the deficit in summation of the GABA 
mediated currents is greater in 0.2 mM of EGTA when compared to the absence of summation in 10 mM 
EGTA concentrations on the application of ATP and α,βme-ATP.  Application of kinase inhibitors also 
failed to have an effect on the deficit in summation (C). 
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Figure 5.1:25.  The involvement of direct coupling in the interaction between P2X and tonic GABAA 
receptors in the central nervous system. 
A, demonstrates the deficit in summation when 1 µM GABA was applied to cortical neurons. B, the 
addition of 10 mM of EGTA or the action of kinase blockers also failed to recover the deficit in 
summation when both agonists were applied together when studying the effects of summation on 
tonically active GABA receptors.  The results suggest tonically active GABAA receptors are also affected 
by the deficit in summation.  Also, it is possible that calcium is not solely responsible for the deficit in 
summation and direct coupling between the receptors may also be involved.  The application of kinase 
inhibitors also failed to have an effect on the deficit in summation (C). Recordings were taken from 
different cells at a holding potential of -80mV. 
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5.2 The absence of reciprocal inhibition of the purinergic receptors by GABAA receptors 
 In the central nervous system GABA is the major inhibitory neurotransmitter which 
regulates excitatory synaptic transmission.  An excitatory neurotransmitter occluding the actions 
of inhibitory transmission in the central nervous system is a relatively novel paradigm.  It has 
been reported that P2X receptors and GABAA receptors can cross-talk with one another on DRG 
neurons.  Sokolova et al. (2001) also noted the non-additive effect when both ATP and GABA 
were applied together as their observed response was much smaller than their predicted algebraic 
sum of the individual responses, probably as one receptor response is inhibiting the other.  They 
concluded that GABAA receptors can occlude P2X receptors and vice versa (Sokolova et al., 
2001).    
 Sokolova et al. (2001) has previously suggested that the down-regulation of P2X-mediated 
currents by activated GABAA receptors is more predominant than the down-regulation of 
GABAA receptor function by P2X-mediated currents.  To study this hypothesis we utilized our 
summation protocol to examine the effects of GABA receptor evoked currents on the summation 
of consecutive P2X receptor-mediated currents.  We recorded a series of control responses to the 
application of ATP to cortical pyramidal neurons followed by the simultaneous activation of 
both receptors.  In high concentrations of calcium chelator (10 mM EGTA) the calcium 
independent deficit in summation was still demonstrated as the amplitude of the observed 
response when ATP and GABA were applied together was still smaller than the theoretical 
response.  The effect of summation was 76 ± 8% n=6, which was statistically significant with a 
confidence level of P=0.05 (verified by one population t-test).   
 In keeping with prior results, the ATP response recorded immediately after the application 
of both receptor agonists was not inhibited (Fig. 5.2:24).  In fact the observed response was 
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slightly potentiated, 105 ± 19% n=6 and statistically significant with a confidence level of 
P=0.05 (one population t-test).   Hence, P2X receptors of the somatosensory cortex were not 
inhibited immediately after the application of GABA, contrary to previous experiments 
conducted on DRG neurons (Sokolova et al.,  2001), which suggests that this negative receptor 
interaction is not reciprocal.  In our own experiments we witness a significantly higher level of 
the deficit in summation in low concentrations of calcium chelator (0.2 mM) compared to high 
levels of EGTA (10 mM).  The small deficit in summation observed in high concentrations of 
EGTA could represent reciprocal inhibition as there may be a decrease in the ATP mediated 
fraction of the current.  This assumption has yet to be studied experimentally; however it is 
consistent with the hypothesis suggested by Sokolova et al. 2001.   
 This difference in experimental evidence may perhaps be due to differences in the subunit 
composition of the P2X receptors.  The most abundant P2X receptor subtype expressed on dorsal 
root ganglion neurons are P2X3 are P2X2/3.  However, neurons of the somatosensory cortex 
show a significant level of expression of the P2X4 receptor subtype.  Both receptor subtypes 
have different functional properties (Grubb and Evans, 1999; North and Suprenant, 2000; Jarvis 
and Khakh, 2009; Nicke et al., 2012) which could account for the diverse results.  
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Figure 5.2:26.  A time course demonstrating the consecutive application of ATP in order to observe 
the impact of activated GABAA receptors on P2X mediated currents on neocortical neurons.  
A previous study suggested that the receptor interaction between ATP and GABA receptors was 
reciprocal on dorsal root ganglion neurons (Sokolova et al 2001).  To study this theory P2X and GABA 
receptor agonists were applied to cortical pyramidal neurons in the central nervous system with 10 mM 
EGTA in the intracellular medium.  The deficit in summation is still significant (*), but the relative lack 
of change in the amplitude of the ATP responses is also noteworthy.  GABAA mediated currents were 
unable to inhibit evoked ATP responses in the somatosensory cortex as previously reported in the 
peripheral nervous system (Sokolova et al., 2001).  Broadly, our results suggest that the functional 
occlusion between the two receptors is not reciprocal in the somatosensory cortex. The boxes represent 
the mean SEM ± for several recordings taken from different cortical neurons.  
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5.3 Discussion 
ATP and GABA are two fast acting neurotransmitters that can be co-released at 
excitatory and inhibitory synapses.  A previous study demonstrated that the functional cross talk 
between ionotrophic P2X and GABAA receptors and postulated that this was a calcium 
dependent mechanism in the peripheral nervous system (Sokolova et al.,  2001).   At high 
concentrations of intracellular calcium the sum of the observed response, where ATP and GABA 
receptors were coactivated, was much smaller than the predicted response, derived from the 
algebraic sum of the individual control ATP and GABA responses.  This effect was not apparent 
in conditions where the intracellular calcium concentrations were low.  However, an opposing 
study reports that this interaction occurs via a calcium independent process called direct 
coupling.  This involves the direct interaction between the intracellular QST motif on the 
carboxyl terminus of the P2X receptor and the intracellular loop on the β-subunit of the GABAA 
receptor.  However, the underlying mechanism for this negative receptor interaction has yet to be 
determined. 
 During our own experiments in the peripheral and central nervous systems we have 
shown that the receptor interaction is calcium dependent and mediated by the impact of PKC 
modulation on phasic and extrasynaptic GABAA receptors.  In spite of this knowledge when both 
receptor agonists were coapplied to patched cortical neurons the recorded response was much 
smaller in magnitude when compared to the predicted sum of both responses in low and high 
EGTA concentrations.  This deficit in summation was also observed when PKC inhibitors were 
introduced to the extracellular solution.  Similar results were obtained when studying this effect 
on extrasynaptic GABAA receptors which mediate tonic inhibition.  Since high EGTA 
concentrations and PKC inhibitors, GF109203x and Staurosporine, failed to recover the absence 
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summation our results are indicative that calcium is not solely responsible for this deficit in 
summation, but direct coupling may also play a role.  Nevertheless, the deficit in summation is 
greater in lower EGTA concentrations when compared to the level of the deficit in higher EGTA 
concentrations.  These results are in line with our previous studies documenting the reduction in 
the GABA receptor currents (ref. Chapter 3) in the peripheral and central nervous systems.  
Therefore, the data highlights that calcium dependent phosphorylation has a more prominent 
effect over direct coupling.   
Studies have suggested that GABAA and P2X receptors are able to reciprocally interact 
with one another, whereby P2X receptors can occlude GABAA receptor mediated responses and 
the same can occur in reverse (Sokolova et al., 2001; Boue-Grabot et al., 2004).  However, our 
own experiments conducted on cortical pyramidal neurons did not show the reported GABAA 
receptor mediated down- regulation of ATP currents.  Generally the deficit in summation is 
marginal in the presence of 10 mM EGTA compared to 0.2 mM EGTA concentrations.  One 
could presume when taking into account our earlier results that the deficit in summation would 
have been recovered in high levels of EGTA.  Clearly the data demonstrates an opposite effect 
which may be interpreted as the reciprocal cross-talk; the ATP mediated component of the 
response is inhibited.  This hypothesis requires further experimental exploration before a more 
definitive explanation can be described.  The dissimilar results could also be due to physiological 
differences between dorsal root ganglion neurons and cortical neurons, which express different 
P2X receptor subtypes.   
In summary, we have shown that the P2X down-regulation of GABAA receptor currents 
is a calcium dependent process involving the activation of and intracellular signalling pathway 
relating to PKC.  However, using high concentrations of calcium chelator in the intracellular 
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solution and application of PKC blockers had no effect on the deficit of summation observed 
when both agonists were applied simultaneously.  Hence, our results unify the two opposing 
theories as the underlying mechanism to this receptor interaction seems to involve predominantly 
a longer-lasting calcium dependent phosphorylation and to some extent direct coupling of the 
intracellular components of the two receptors.  
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Chapter 6 
 
The physiological consequences of the 
P2X driven down-regulation of GABAA 
receptors in the central nervous system 
 
6.0 Introduction 
The expression of P2X receptors on neurons has been demonstrated in many brain areas 
(Burnstock, 1976; Buell et al., 1996; North, 1996; North, 2002; Illes and Ribeiro, 2004), but 
recent evidence suggests that they also reside on a second type of cell in the brain, glial cells 
(Verkhratsky et al., 2009).  Astrocytes, a type of glial cell in the central nervous system, are non-
excitable cells.  Research examining the precise function of glial cells in the central nervous 
system has remained dormant as they have forever been observed as supporting cells to neurons. 
The glutamate induced oscillations in the intracellular calcium concentration in astrocytes 
(Cornell-Bell et al., 1990; Charles et al., 1991), causes the activation of an intracellular signalling 
cascade involving inositol trisphosphate (IP3) and the release of calcium from intracellular 
stores.  This finding engendered a flurry of research into the potential role of astrocytes in 
modulating neurotransmission.  Furthermore, evidence that astrocytes enwrap synapses, express 
a multitude of receptors and release gliotransmitters such as ATP, D-Serine and glutamate 
signified that they played a significant role in regulating neuronal function and excitability.  
   Cytosolic calcium plays a fundamental role for non-excitable cells in inter- and 
intracellular communications (Braet et al., 2004).  Accumulating evidence suggests that ATP 
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may arbitrate Ca
2+
 transmission (Wang et al., 2000), thus increasing the levels of cytosolic 
calcium in glial cells and neurons as part of the tripartite synapse.  Neuronal stimulation is able 
to induce Ca
2+
 signalling in astrocytes, which in turn is able to propagate back to neuronal 
synapses to modulate synaptic transmission, highlighting the potential of purinergic regulation of 
synaptic transmission mediated by Ca
2+
 ion conductance.  
 
  
   There has been a plethora of studies which describe the induction of an important 
mechanism associated with learning and memory termed long term potentiation (LTP), 
particularly in the CA1 region of the hippocampus (Weirazko, 1996; Fuji, 2004; Yamazaki et al., 
2003; Henneberger and Rusakov, 2010; Ievglevskyi et al., 2012).  However, research has also 
demonstrated that the neocortex is also linked to learning and memory (Castro-Alamancos et al., 
1995) and neuroimaging studies revealed that patients suffering from amnesia showed activation 
of regions within the neocortex when asked to recall information (Purves, Neuroscience 2004).   
LTP is an important mechanism that involves an increase in synaptic efficacy associated with 
learning and memory.  It has been demonstrated that silent synapses where there is an absence of 
AMPA receptors are transformed to functional synapses by the induction of LTP in 
thalamocortical slices (Isaac et al., 1997).  LTP is state dependent (requires the coupling of both 
pre- and postsynaptic activity), exhibits input specificity (potentiation is restricted to active 
synapses) and also displays associativity (weak and strong stimulation occurs simultaneously at 
neighbouring synapses and both synapses are strengthened) (Bliss and Collingridge, 1993).  
These unique features of LTP indicate that it is a useful mechanism for memory development.   
 LTP can be induced in the central nervous system by two main mechanisms, which 
include: an elevation in the quantity of neurotransmitter released from the presynaptic cell; an 
increase in the functional expression of receptors on the postsynaptic membrane and disruptions 
  
112 
 
in the uptake and degradation methods of specific neurotransmitters (Bliss and Collingridge, 
1993).  The mechanism of LTP induction involves the activation of the receptors expressed on 
the postsynaptic membrane, predominantly glutamate NMDA receptors.  An increase in 
intracellular calcium levels via influx through the NMDA receptor channel is vital for the 
induction of LTP.  Lisman et al. (2002) proposed that the direction of the changes in synaptic 
plasticity whether it be potentiation or depression is dependent on the extent of the calcium 
influx into the cell (Malenka et al., 1988).  A high magnitude of calcium influx causes LTP by 
activating secondary messenger CamKII and a low calcium influx activated by calcineurin 
causes Long Term Depression (LTD) (Lisman et al., 2002).  Therefore, NMDA receptors are a 
primary source of calcium on the postsynaptic cell, which activates intracellular signalling 
cascades to produce LTP in the brain.   
Many studies have demonstrated that ATP plays a significant role in the induction of long 
term potentiation (LTP) with particular emphasis on the CA1 region of the hippocampus (Fujii et 
al., 1995, 2002, 2003, 2004; Pankratov et al., 2009).  Yamazaki et al. (2003) demonstrated that 
the application of ATP onto hippocampal CA1 neurons elicited LTP in neurons showing small 
Ca
2+ 
currents, whereas (Long Term Depression) LTD was detected in neurons exhibiting larger 
Ca
2+ 
currents.  Thus, there is a considerable correlation between the enormity of the long-term 
changes in plasticity and the size of Ca
2+ 
signals following ATP application (Yamazaki et al., 
2003).   The P2X receptors high permeability to Ca
2+ 
even at resting membrane potentials makes 
them perfect candidates to mediate synaptic plasticity in the central nervous system.   
    
 
   Long term changes in synaptic efficacy are maintained by alterations in gene expression, 
which frequently occur in the neocortex and has Hebbian properties i.e. an increase in 
stimulation to the presynaptic neuron causes and increase in synaptic strength (Bliss and 
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Colligridge, 1993).  LTP in the neocortex can be induced by signalling to the presynaptic 
terminal as a mechanism to increase the release probability.  Glial cell derived signalling 
molecules coined gliotransmitters act on the postsynaptic membrane to modulate NMDA 
receptors and effecting the facilitation of LTP in the central nervous system.  D-Serine is 
produced in neurons and glial cells as they harbour serine racemase, which catalyses the 
conversion of L-serine into D-Serine (Haydon and Carmignoto, 2006).  Once released D-Serine 
diffuses across to the postsynaptic NMDA receptors, binding to the glycine site.  Consequently, 
there is a significant rise in the field Excitatory Postsynaptic Potential (fEPSP) (ref. Chapter 2, 
Fig. 2.9:7) as the NMDA receptors are not saturated under resting conditions (Henneberger and 
Rusakov, 2010).  Hence, gliotransmitters are also accountable for modulating NMDA receptors 
and thus inducing long term potentiation.
 
Growing evidence shows that glial derived ATP is involved in the induction of long term 
potentiation (LTP).  Vesicularly released ATP is able to modulate the activity of postsynaptic 
NMDA receptors by activating intracellular secondary messengers such as PKA in a calcium 
dependent manner (Pankratov et al., 2002a).  Furthermore, we have shown previously that 
astroglial derived ATP is able to inhibit both phasic and tonic GABAA receptors on the 
postsynaptic membrane in the somatosensory cortex (Lalo et al., 2009).  Extracellular ATP 
released from glial cells also acts postsynaptically to enhance the expression of AMPA receptors 
on the postsynaptic membrane and thus increasing the level of synaptic efficacy.  This effect can 
be blocked by glial cell toxin fluoroacetate (FAC) (Haydon and Caramignoto, 2006; 
Henneberger and Rusakov, 2010). Therefore, extracellular ATP’s unique signalling properties 
and modulatory capabilities as part of the tripartite synapse could also contribute to the formation 
  
114 
 
of learning and memory in the neocortex.  However, the specific role of astrocytes in synaptic 
plasticity in the neocortex has yet to be fully determined.  
6.1 The induction of LTP in cortical slices 
Under control conditions the induction of LTP was recorded to test the suitability of the 
designed stimulating protocol in inducing the potentiation of the postsynaptic response in cortical 
brain slices.  The stimulating electrode was placed in layer IV-V of the neocortex (involved in in 
callosal and ipsilateral corticocortical circuits) and the recording electrode was positioned in 
layer II/III to record the postsynaptic response opposite the stimulating electrode.  Before 
initiating any stimulation to the slice stabilisation of the baseline was essential before starting the 
experiments as this would act as a control, defined as the period before the induction of LTP and 
referred to as 100% during analysis of the fEPSP slope.  Therefore, a delay of 10-20 minutes was 
required before the administration of any form of electrical stimulation to the brain slice. 
To produce an enhancement in synaptic efficacy a standard Theta Burst Stimulation 
(TBS) protocol was used, which consisted of a 0.5 second train at 100Hz.  There were a total of 5 
trains which were delivered at 10 second intervals.  Previously, experimental data demonstrated 
that depending on the age of the animal shorter trains consisting of 2 or 3 were not sufficient in 
inducing LTP in the neocortex (data not shown).  Once the baseline had stabilised a TBS of 5 
pulses was applied to layer IV-V of the neocortex with an amplitude that ranged between 0.5 and 
3 Amps producing an EPSP that reached a plateau lasting between 40-60 minutes each time (Fig. 
6.1: 25).  Using this configuration, recording from layer IV-V using this standard TBS protocol 
produced a clear EPSP which can be reproduced for more than two hours whilst recording, 
without any run-down of the EPSP and a stable amplitude was recorded in approximately 80% of 
all cortical slices.    
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Figure 6.1:27.  Long term potentiation induced electrically by TBS in cortical brain slices.   
The standard Theta Burst Stimulation (TBS) used throughout the study of LTP is sufficient to produce 
enhancements in synaptic efficacy in cortical slices under control conditions.  After the baseline has 
stabilised TBS is elicited and there is a significantly large increase in the fEPSP slope, which gradually 
decreases to a stable plateau 20 minutes after TBS.  The control experiments confirm that LTP could be 
induced using a train of high frequency stimulation like the standard TBS protocol.  Data points represent 
the mean ± SEM of recordings from slices.  The results were statistically significant with a confidence 
level of P=0.001 (one population t-test).   
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6.2 The involvement of gliotransmitters in LTP induction 
Once thought as dormant cells, which function as supporting components to neurons and 
fundamental to the maintenance of homeostasis in the brain, there is now a plethora of evidence 
that suggests astrocytes contribute and modulate synaptic transmission.  Since they are also able 
to release gliotransmitters which can act on the pre- and postsynaptic membranes suggests that 
their potential as mediators of synaptic signalling as part of the tripartite synapse is of paramount 
importance. 
Astroglial cells express multiple receptors, many of which are also expressed on neurons.    
The release of neurotransmitters from the presynaptic terminal causes the activation of the 
functional receptors expressed on astrocytes.  Consequently, the activation of the astroglial 
receptors produces a calcium influx and causes oscillations in the intracellular calcium 
concentration in the astrocytes. The rise in intracellular calcium leads to the release of 
gliotransmitters such as ATP, glutamate and D-Serine (Zhang and Haydon, 2005).   
It has been established that the external application of gliotransmitter D-Serine to brain 
slices produces an increase in LTP in the postsynaptic response at the Schaffer collateral 
pyramidal cell synapse of the CA1 region in the hippocampus (Henneberger and Rusakov, 2010).  
Due to the fact that D-Serine is produced in glial cells, which contain D-Serine racemase, 
responsible for the conversion of L-serine to D-Serine (Haydon and Carmignoto, 2006) makes it 
an ideal candidate out of the selection of gliotransmitters to induce LTP.   The calcium 
dependent release of D-Serine results in its diffusion across to the postsynaptic membrane as an 
agonist to the glycine binding site on the NMDA glutamate receptors.   Research has 
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demonstrated that D-Serine is the co-agonist to NMDA receptors in the hippocampus during 
LTP (Panatier et al., 2006). 
During our own experiments conducted in the neocortex, D-Serine was applied 10 
minutes before and 10 minutes after the TBS stimulation.  It was discovered that rather than the 
initial increase and gradual sustained plateau which was observed in the control experiments, 
LTP under D-Serine appears to be inhibited as an increase in synaptic plasticity was not 
observed (Fig. 6.2:26).  The effect of D-Serine was statistically significant with a confidence 
level of P=0.005 (one population t-test).  The discrepancy between the data could be due to the 
concentration of D-Serine already being relatively high in the neocortex and therefore neuronal 
NMDA receptors are already saturated unlike the CA1 hippocampal pyramidal neurons 
(Henneberger and Rusakov, 2010). The failure of D-Serine to cause LTP is the neocortex 
overshadows the potential of gliotransmitters to induce LTP, however further study in required to 
determine the role of gliotransmitters in learning and memory, specifically in the neocortex.   
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Figure 6.2:28.  Gliotransmitter D-Serine does not induce LTP in the cortex. 
D-Serine is released from astroglial cells and binds to the glycine binding site on the NMDA receptor.  
The application of 3 μM D-Serine 10 minutes before the implementation of TBS and 10 minutes 
afterwards causes a depression in LTP contrary to previous reports (Henneberger and Rusakov, 2010).  
This effect was statistically significant with a confidence level of P<0.005. 
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6.3 The role of glial cells in the induction of LTP in the neocortex 
The gliotransmitter D-Serine surprisingly did not provide the expected potentiation of the 
postsynaptic response in the neocortex.  Therefore, it was important that the role of glial cells in 
LTP the neocortex was established.  Calcium signalling is essential to the induction of D-Serine 
activated NMDA receptor LTP as the vesicular release of D-Serine from astrocytes is calcium 
dependent.  However, loading an astroglial cell with calcium chelators had no effect on the 
induction of synaptic plasticity in hippocampal CA1 pyramidal neurons (Diamond et al., 1998).  
However, another study demonstrates that by clamping the intracellular calcium concentration 
inside the astrocytes potentiation of the fEPSP was blocked as a result of a decreased level of 
NMDA co-agonist occupancy on the glycine binding site (Henneberger and Rusakov, 2010).  
Therefore the physiological relevance of astrocytes in learning and memory remains 
controversial.  To study the possible involvement of glial cells in the enhancement of synaptic 
plasticity we applied Fluoroacetate (FAC) to cortical slices.  FAC is a glial metabolic toxin and 
is selective for astrocytes because their membranes are more permeable to FAC than neurons 
(Hassel et al., 2002), due to the presence of acetate transporters on the astrocytes.  FAC targets 
the TCA cycle specifically and has been shown to inhibit LTP in the hippocampus even with a 
high frequency stimulation protocol (Henneberger and Rusakov, 2010).   
 The application of 3 mM FAC in the extracellular solution to the slices occurred 20 
minutes before the implementation of the standard TBS protocol and also continued 60 minutes 
afterwards.  Unlike the control where there is a significant increase in the amplitude of the EPSP 
slope as a consequence to the induction of LTP, under FAC LTP induction is inhibited.  In fact 
there were no considerable changes in the fEPSP slope and it remained fixed at approximately 
100% for the entire duration of the experiment.  The effect of FAC on long term potentiation in 
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the neocortex was statistically significant with a confidence level of P=0.01 (one population t-
test).  Therefore, the action of FAC which is known to target the metabolic cycle of glial cells 
and its effect on inhibiting the induction of LTP, suggests a role for glial cells in the development 
of synaptic plasticity in the neocortex. 
 The impairment of the induction of LTP by clamping the intracellular concentration 
inside individual astrocytes can be reversed by exogenous D-Serine (Henneberger and Rusakov, 
2010).  Hence, we used this hypothesis to rescue the occlusion of astroglial cell induced LTP by 
co-applying D-Serine to the slice with FAC.  The combined application of FAC and D-Serine 
occurred 10 minutes before TBS and for 60 minutes after TBS (Fig. 6.3:27).  The amplitude of 
the fEPSP slope declined by approximately 85% after TBS and eventually stabilised to control 
level (100%).  No potentiation was observed 20 minutes later.  This effect was statistically 
significant with a confidence level of P=0.02 (one population t-test).  Therefore, our results 
indicate that although the data suggests that astrocytes are involved in the induction of LTP 
gliotransmitter D-Serine was not able to recover LTP under the inhibitory actions of FAC.  
 To further investigate the role of glial cells in the generation of LTP in the neocortex we 
employed genetically modified dominant negative SNARE mice (dnSNARE).  dnSNARE mice 
are useful in studying the physiological consequences of astrocytes as they express a dominant 
negative SNARE complex in astrocytes (Pascual et al., 2005).  The SNARE complex is an 
important functional feature of the vesicular release machinery in neurons and astrocytes for the 
exocytosis of transmitters.  Astroglial cells in the hippocampus expressing the dnSNARE gene 
exhibited a decrease in the levels of LTP induced by TBS, implicating a role for glial cells in 
long term potentiation.    
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Administering the standard TBS protocol to layer IV-V of the neocortex of the 
dnSNARE brain slices failed to produce the effects of LTP (Fig. 7.3:28).  There was only a 
minute increase in the fEPSP slope from the 100% control level in the dnSNARE mice, contrary 
to the results obtained in wild type mice.  The effect of dnSNARE mice on LTP on glial cells in 
the neocortex is statistically significant with a confidence level of P=0.005 (one population t-
test).  Therefore, the dysfunctional vesicular release apparatus of dnSNARE mice means that 
gliotransmitters cannot be released to modulate the neuronal NMDA receptors on the 
postsynaptic membrane, inferring a role to gliotransmitters in the induction of LTP.   
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Figure 6.3:29. The inhibition of Long-term potention by glial cell toxin Fluroacetate (FAC). 
A, the application of specific glial cell metabolic toxin 3 mM FAC blocked the induction of LTP in the 
neocortex, indicating a role for glial cells in modulating synaptic plasticity. B, D-Serine was unable to 
recover the abolishment of LTP mediated by FAC when co-applied with the metabolic poison.  Therefore, 
the data suggests that glial cells play a significant role in LTP induction.  Then data presents the mean+/-
SEM, for n=8 and n=7 respectively, of FAC and FAC + D-Serine applications. Effects were statistically 
significant with confident levels of P=0.01 and P=0.02 respectively.  
1 mV 
20 ms 
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Figure 6.3:30.  SNARE complex deficient transgenic dnSNARE mice inhibit LTP in the neocortex. 
A comparison between control experiments conducted on both wild type mice and dnSNARE mice 
suggests a role for gliotransmitters in the induction of LTP.  The data shows the mean+/-SEM, for n=12, 
of the dnSNARE control experiments which were statistically significant with a confidence level of 
P=0.005. 
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6.4 The role of glial derived ATP in the induction of LTP 
Previously, observations have suggested that the functional linkage between NMDA 
receptor mediated LTP and glial cells is the release of gliotransmitters from astrocytes, with 
particular emphasis on D-Serine.  When we apply specific astroglial cell metabolic toxin FAC to 
the cortical slices there is no potentiation of the fEPSP slope as observed in the control and D-
Serine is not able to reverse this effect.  Therefore, this suggests the involvement of glial cells as 
a facet in the mechanism for LTP induction, but questions the involvement of D-Serine in 
synaptic plasticity in the neocortex.  The role of glial cells is also highlighted when dnSNARE 
mice also fail to elicit LTP as the there is a deficit in the release of gliotransmitters to act on the 
postsynaptic membrane. 
Using the dnSNARE mouse model we applied 3 μM of D-Serine to cortical slices in the 
extracellular solution 10 minutes before TBS and for 10 minutes after TBS.  When comparing 
the control dnSNARE experiments with the application of D-Serine, it is apparent that there is no 
significant difference between the two effects.  There is no potentiation of the fEPSP in the 
dnSNARE control and the amplitude of the fEPSP slope remains at approximately 100% 
throughout the experiment.  Similarly, there is no potentiation upon the application of D-Serine 
in dnSNARE mice (Figs. 7.3:28 and 7.4:29).  The effects of dnSNARE mice and D-Serine were 
not statistically significant, despite resulting in similar effects on LTP induction. 
It is widely acknowledged that extracellular ATP is a major component in the tripartite 
synapse and can be released from neurons to modulate pre- and postsynaptic receptors.  The 
release of ATP from glial cells can also impact the function of postsynaptic receptors.  We have 
previously studied the calcium dependent release of astroglial ATP in the neocortex using a 
“sniff cell” approach and cultured HEK-293 cells (Lalo et al., 2009).  The HEK-293 cells were 
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transfected with P2X2 receptors and produced a burst of pulsatile currents when astroglial cell 
PAR-1 receptor agonist TFLLR was applied, which were later inhibited by P2X antagonist 
PPADS.  Hence, the data suggests that ATP release from the adjacent astrocytes triggers the 
pulsatile currents in the HEK293 cells which are mediated by activated P2X receptors.  Also, the 
acutely isolated cortical astrocytes which were loaded with calcium indicator Fluo-4 AM 
displayed elevated intracellular calcium levels upon PAR-1 receptor activation.  Therefore it is 
natural to assume that astroglial derived ATP can effect postsynaptic GABAA receptors in a 
calcium dependent manner and modulate the induction of LTP. 
We have shown that astroglial cell derived ATP is able to modulate GABAA receptors 
expressed on neocortical pyramidal neurons (Lalo et al., 2009). Thus, we studied the effects of 
extracellular ATP on LTP in the neocortex.  An analogue of ATP called ATPγS has been 
demonstrated to induce LTP in the hippocampus (Weirazko, 1996) and it selectively activates 
P2X1 and P2X1/5 which are abundantly expressed on astrocytes (Rettinger et al., 2000; Palygin 
et al., 2010).  ATPγS (10uM) was applied 10 minutes before and for 10 minutes after electrical 
stimulation.  After the removal of ATPγS there is a gradual increase in the fEPSP slope which 
results in a stable plateau for more than 60 minutes.  This effect is reminiscent of the induction of 
LTP in wild type mice (Fig. 6.2:28).  Although the period of time for the potentiation to be 
exhibited is longer in dnSNARE mice, it is evident that ATPγS is competent in its abilities to 
rescue the neocortical LTP phenotype (Fig. 6.4:29).  The effect of the ATPγS application was 
statistically significant when compared to the dnSNARE mice control experiments with a 
confidence level of P=0.02.  Therefore the data suggests that the induction of LTP in cortical 
slices also includes a purinergic component, which influences the activation of NMDA receptors 
expressed on the postsynaptic membrane to enhance synaptic efficacy.  Furthermore, the fact that 
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LTP can be generated even in dnSNARE mice indicates that glial cells themselves are not 
important, but it is the gliotransmitters that they release and the resulting signals that they exert 
on neuronal receptors. 
 The positive response subsequent to the application of ATPγS on inducing LTP in 
cortical slices after electrical stimulation was further established with the use of ionotrophic 
receptor blockers in a series of experiments.  Research on NMDA receptors has predominantly 
focused on those expressed on neurons and the function of NMDA receptors expressed on glial 
cells was considered inconsequential.  This is mainly due to the voltage dependent Mg2+ block, 
which many perceived would mean that glial NMDA receptors would be inactive at resting 
membrane potentials (Palygin et al., 2011).  Despite previous thoughts it has been noted that 
astroglial cells (Lalo et al., 2006) in particular express NMDA receptors which are of a different 
subunit composition to neuronal NMDA receptors and are not subject to Mg
2+
 block of their 
channel pores at physiological concentrations (Karadotir et al., 2005; Lalo et al. 2006).    
The most ubiquitous NMDA receptor subunit expressed on glial cells is NR2C.D. 
UBP141 is a potent inhibitor of NMDA receptors which contain NR2C,D subunits and thus is a 
selective blocker of glial cell signalling.  It had a modest inhibitory action on NMDA receptors 
expressed on cortical pyramidal neurons (Palygin et al., 2011), which makes it a useful tool in 
studying glial cell induced LTP.  The NMDA receptor blocker was washed in to the recording 
chamber on to cortical slices of wild type mice 10 minutes before TBS and removed immediately 
afterwards.  Under the application of UBP141 there was no induction of LTP it the cortical slices 
instead we observed a small decrease in the fEPSP slope after the electrical stimulation which 
was maintained throughout the majority of the experiment and progressively increased back to 
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control level of 100%.  The effect of UBP141 was statistically significant with a confidence level 
of P=0.02 (one population t-test).   
The application purinergic receptor inhibitor NF449 which selectively blocks P2X1 and 
P2X1/5 receptors also impaired the induction of LTP when it was applied 20 minutes before 
TBS and for 60 minutes afterwards.  These P2X receptor subtypes were shown to be 
predominant in the purinergic signalling of cortical astrocytes (Lalo et al., 2008), contrary to 
neurons where P2X2, 3 and 4 receptors made a major contribution.  Therefore, NF449 could be 
considered as a blocker of glial purinergic signalling in our experimental context.  The response 
of the fEPSP to the NF449 application paralleled that of UBP141 as again the fEPSP slope 
decreased for a considerable amount of time and gradually returned back to 100% (Fig. 6.4:30).  
The effect of the preferential inhibition of glial P2X receptors by NF449 is statistically 
significant with a confidence level of P=0.01 (verified by the one population t-test).  The 
inhibition LTP by blocking P2X1 and P2X1/5 purinoceptors suggests that these particular 
astroglial purinergic receptors are responsible in the mechanism of ATP driven LTP.  
Furthermore, the above data suggests that the functional relationship of LTP in the neocortex is 
between the NMDA and P2X receptors.  The precise underlying mechanism of ATP induced 
LTP remains unclear and requires further investigation. 
 
 
 
 
 
  
128 
 
1 mV
20 ms
 control
 ATPgS, n=6
 60 min after TBS
A  
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
Figure 6.4:31.  Different roles for glia-driven ATP and D-serine in induction of synaptic plasticity in 
the neocortex.  
  
3 µM of D-Serine was applied to cortical slices 10 minutes before the electrical stimulation and for 10 
minutes afterwards.  D-Serine was unable to recover LTP in dnSNARE mice.  A and B, the action of 
10μM ATPγS which was applied for the same time frames as D-Serine induced LTP in dnSNARE mice, 
suggesting a purinergic role in the induction of LTP and confirming that D-Serine does not contribute to 
LTP in the neocortex.  Both effects were statistically significant with confidence levels of P=0.02 and 
P=0.01 (one population t-test) respectively.  However the effect of D-Serine was not statistically 
significant when compared to the control dnSNARE experiment.  
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Figure 6.4:32.  Impairment of exocytosis of gliotransmitters dramatically reduced the magnitude of 
LTP in the dn-SNARE mice.   
Attenuation of GABA receptors by antagonist gabazine (150 nM) significantly increased the magnitude 
of LTP in dnSNARE mice.  In the presence of gabazine, D-Serine became capable to increase the LTP 
magnitude in the neocortex of dnSNARE mice. These data suggest that down-regulation of inhibitory 
receptors by ATP released from astrocytes is essential for the induction of LTP in the neocortex. 
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Figure 6.4:33. The inhibition of Long-term potentiation by glial specific ionotrophic receptor 
blockers in wild type mice. 
The standard TBS protocol is able to elicit LTP in the neocortex of wild type mice.  However, the 
application of 3mM UB141, a glial specific NMDA receptor blocker prevents the induction of LTP by 
electrical stimulation in the neocortex.  Similarly, with application purinergic receptor blocker NF449 (3 
µM), which specifically blocks P2X1 and P2X1/5 receptor subtypes which are abundantly expressed on 
glial cells no potentiation of the fEPSP slope is observed.  Both of the effects were statistically significant 
with confidence levels of P=0.02 and P=0.01 respectively.  
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6.5  Discussion 
 In recent years a significant effort has been devoted to defining the role of ATP derived 
from glial cells in the central nervous system with a strong emphasis on the action of astrocytes 
in mediating synaptic transmission.  It is wildly acknowledged that glial cells express receptors 
which are also expressed abundantly on neurons and also possess the cellular machinery to 
release chemical transmitters into the synaptic cleft such as D-Serine, ATP and glutamate.  
Consequently, astroglial cells are able to integrate themselves into the synapse and mediate 
neuronal signalling as part of the tripartite synapse.  Numerous studies have shown that ATP 
plays a fundamental role in the induction of long term potentiation in the CA1 region of the 
hippocampus (Fujii et al., 2004) as well as the possibility of glial cells also being involved in the 
development of learning and memory (Pankratov et al., 2008). 
 Since most of the work on synaptic plasticity has been conducted in the hippocampus we 
focused our attention to the neocortex.  Under control conditions LTP was induced by a 5 pulse 
Theta Burst Stimulation (TBS) protocol (Fig. 6.1:25).  In nearly all of the slices LTP was elicited 
using the same electrical stimulation protocol which was applied to layer IV-V and detected in 
neurons in layers II/III of the neocortex.  Consequently, there was a potentiation of the fEPSP 
slope of approximately 30%, which was prolonged for more than 60 minutes after TBS, 
signifying LTP induction.  The high frequency stimulation to presynaptic neurons in layer IV-V 
produces potentiation via elevated neurotransmitter release, which in turn influences astrocytes 
and postsynaptic neurons to generate LTP. 
 The external application of gliotransmitter D-Serine to brain slices produces an increase 
in the potentiation in the postsynaptic response recorded at the Schaffer collateral pyramidal cell 
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synapse of the CA1 region in the hippocampus (Henneberger and Rusakov, 2010).  This is a 
plausible hypothesis as D-Serine is stored and created in astrocytes which harbour serine 
racemase, which is accountable for converting L-serine into D-Serine.  Once released it binds to 
the glycine site on the postsynaptic NMDA receptor to modulate the channels function.  On the 
contrary to the reported results, the external application of D-Serine to the cortical slices had 
almost no effect, 4% potentiation was recorded and LTP was not induced.  The divergence in the 
results could be a result of the higher concentration of D-Serine in the neocortex compared to the 
hippocampus, which means that the neuronal NMDA receptors are already saturated.  Also, the 
expression of different NMDA subtypes may also be critical as the presence of non-conventional 
NMDA receptors can be desensitised to D-Serine when the membrane potential is too strong, 
causing an inhibitory effect.  This would require further investigation to elucidate the expression 
levels of such NMDA receptors on cortical neurons and glial cells. 
 To deduce the role of astrocytes as mediators of enhancing synaptic efficacy in the 
neocortex we employed methods to impair the function of glial cells.  Fluoroacetate (FAC) is a 
specific glial metabolic toxin which inhibits the tricarboxylic acid cycle (TCA cycle).  Studies 
have reported that D-Serine is able to increase the amplitude of NMDA receptor EPSCs in CA1 
pyramidal cells, suggesting that the NMDA receptors are not saturated in resting conditions 
(Henneberger and Rusakov, 2010).  However, the application of FAC to the cortical brain slices 
resulted in the inhibition of LTP by electrical stimulation and could not be rescued by the 
application of D-Serine (Fig. 6.9:27).  It was suggested that under FAC glial cell function is not 
fully impaired and as a result a resting level of D-Serine is released from the remaining 
functioning cells.  Subsequently the tonic concentration of D-Serine is sufficient to activate the 
postsynaptic NMDA receptors.  Since the NMDA receptors in the neocortex are already highly 
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saturated the tonic D-Serine current will have no resulting effect.  When glial cell function is 
deficient in the neocortex LTP induction fails and cannot be recovered by D-Serine in the 
neocortex.  Hence, the data assigns an important role to glial cells in LTP induction and suggests 
the involvement of gliotransmitters in learning and memory in the neocortex.      
 Glial cell signalling can also be abolished by specific glial cell ionotrophic receptor 
antagonists.  The strong inhibitory action of UBP141 is restricted to NMDA receptors expressed 
on glial cells as they are composed of NR2C,D subunits which are not found in neuronal NMDA 
receptors.  When NMDA blocker UBP141 was applied there was no induction LTP by TBS (Fig. 
6.4:30).  Glutamate NMDA receptors are a primary source of calcium influx into glial cells via 
activation of glutamate released from the presynaptic membrane.  Therefore, the intracellular 
calcium concentration is not increased and gliotransmitters cannot be exocytosed from the 
astrocytes which is a calcium dependent process.  The inhibition of this signalling pathway 
prevents LTP and highlights the essential role of glial cells in facilitating the induction of LTP. 
The most predominant functional P2X receptor subtypes expressed on astrocytes are 
P2X1 and P2X1/5 receptors. Application of a specific blocker of these P2X receptor subtypes, 
NF449 obstructed the induction of LTP by electrical stimulation.  Hence, extracellular ATP is 
unable to activate the glial cell specific P2X receptors and there is no influx of calcium, parallel 
to the results obtained under UBP141.  The experimental data underlines the significance of glial 
NMDA and P2X receptors in LTP induction.  The released gliotransmitters (ATP and D-Serine) 
as a result of receptor activation act on the neuronal receptors on the postsynaptic membrane and 
modulate their function, such as ATP down regulating GABAA receptors which can facilitate 
LTP caused by elevated excitatory neurotransmission.   
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The presence of both NMDA and ATP receptors has been described as being 
fundamental for the induction of LTP when the application of NMDA alone failed to facilitate 
synaptic plasticity in the same way that the co-application of ATP and NMDA did in the 
hippocampus (Fujii et al., 2003).  The role of glial derived ATP is to enhance the action of 
NMDA by causing transient increase in the intracellular calcium concentration on the post 
synaptic membrane.  ATP causes the depolarisation of the postsynaptic membrane, which in turn 
removes the magnesium block of the neuronal NMDA receptor channel producing a source of 
calcium influx into the cell.   Lisman et al. (2002) postulated that the extent of the increase in the 
intracellular calcium concentration drives the direction of the plasticity (Lisman et al., 2002).  A 
large influx of calcium facilitates LTP which can be provided by the activation of NMDA by 
glial derived ATP.  A consequence of the ATP evoked calcium influx is the activation of 
intracellular signalling cascades to produce ATP induced LTP (Fujii et al., 2004).   
 The role of glial cells in synaptic plasticity was reconfirmed in cortical slices taken from 
dnSNARE mice where the vesicular release apparatus are impaired.  Electrical stimulation of the 
slice in layer IV-V produced no LTP induction and the same occurred under the influence of D-
Serine.  The function of the TBS protocol is to depolarise the presynaptic cells for the release of 
neurotransmitters which then bind to receptors expressed on the postsynaptic membrane and glial 
cells.  Although the glial cells will be able to respond to the binding of the corresponding agonist 
to its receptors producing oscillations in the intracellular calcium concentration, the astroglial 
cells are deficient in releasing any gliotransmitters in dnSNARE mice to act on the postsynaptic 
membrane.  Thus, long term potentiation cannot be induced in this transgenic mouse model and 
highlights the importance of the release of gliotransmitters in this mechanism of learning and 
memory. 
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 The application of non-hydrolysable ATP analogue ATPγS was able to facilitate LTP 
caused by electrical stimulation in dnSNARE mice.  However, it is unclear whether ATPγS alone 
could produce LTP without the aid of the TBS protocol.  One of the direct mechanisms of ATP 
action on synaptic plasticity could be reducing the threshold required to induce LTP by inhibiting 
GABAA receptor activity via activation of P2 on the postsynaptic membrane.  The reduced 
activation of postsynaptic receptors in dnSNARE mice, particularly NMDA receptors, may be a 
cause for the absence of an effect by D-Serine on LTP in the neocortex.  To conclude, the fact 
that LTP can be induced even in dnSNARE mice, it is not the glial cells themselves that is 
important but it is the release of gliotransmitters such as ATP and D-Serine and the signals that 
they exert on the postsynaptic membrane that contribute to the development of learning and 
memory.   
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Chapter 7 
Discussion 
 
The data obtained from this series of experiments show that the activity of the GABAA 
receptors were affected by the activation of the P2X receptors expressed in both the peripheral 
and central nervous system.  Our results suggest that the entry of calcium through the purinergic 
ion channel served as a signalling molecule to facilitate the modulation of the inhibitory 
receptors and acted as the functional linkage between the P2X and GABAA receptor responses.   
Moreover, the presented results maintain the ideology that enhanced intracellular calcium 
concentrations leads to the activation of intracellular signalling cascades which are responsible 
for the phosphorylation of the GABAA receptor. The examination of the underlying mechanism 
of this receptor interaction is not very well explored, however endeavouring to do so has led to 
the discovery of a calcium dependent pathway which points to the involvement of an 
intracellular signalling kinase, Protein Kinase C that is fundamental to this novel receptor 
communication. 
There are two main factors which emphasise the significant role of the calcium dependent 
component of the purinergic driven down regulation of GABAA receptors.  Firstly, when the 
levels of calcium chelator was enhanced in the intracellular medium (10 mM EGTA) the action 
of the P2X receptors on GABAA receptor currents when activated with ATP or P2X specific 
agonist α,βme-ATP was abolished.  On the contrary the opposite effect was observed in low 
concentrations of calcium chelator (0.2 mM EGTA), which promoted the occlusion of the 
GABA mediated currents recorded immediately after the activation of the ATP receptors on both 
  
137 
 
DRG and central neurons.  These results are parallel with another group that have also shown the 
calcium dependent inhibition of GABAA receptor evoked currents by P2X receptors in DRG 
neurons (Sokolova et al., 2001), which is in disagreement with another group who postulate that 
the receptors communicate via direct coupling (Boue-Grabot et al., 2004; Toulme et al., 2007)  
Secondly, functional P2X receptors exhibit a high permeability to calcium at low membrane 
potentials, which means they are a prime source of calcium influx into the cell.  Therefore, the 
inhibitory influence of P2X receptors on GABAA receptors is most likely to be dependent on the 
calcium influx through the purinergic ion channel.   
 Early on during our experiments conducted on DRG neurons we noted that the amplitude 
of the control GABA responses were significantly variable in 0.2 mM EGTA intracellular 
solutions, but gradually stabilized after consecutive applications of receptor agonist.  The 
variability in GABA mediated responses was not observed in 10 mM EGTA concentrations, 
further emphasizing the magnitude of the calcium dependence to this receptor interaction.  Other 
groups have established this receptor interaction by focusing on a comparison between the 
predicted algebraic sum of the co-application of ATP and GABA and the actual response to the 
simultaneous application of two agonists recorded during their experiments.  This method is 
severely influenced by the rundown of GABAA currents, which as we have observed is inevitable 
when using a lower concentration of Ca
2+
 chelator inside the cell, and may underestimate the 
impact of activated P2X receptors on the GABA mediated responses.  This could explain  the  
controversy between the data of two different research groups (Sokolova et al., 2001; Boue-
Grabot et al., 2004; Toulme et al., 2007;  Jo et al., 2011).  The method we used during our own 
experiments is significantly more robust and more sensitive towards the rundown of the GABA 
response. 
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 Experimental evidence suggests that calcium may not be solely responsible for GABAA 
and P2X interactions as the functional state of the GABAA receptors themselves may play a 
significant role.  NMDA receptors expressed on hippocampal neurons are also subjects of the 
P2X mediated down regulation via a calcium dependent mechanism involving phosphorylation 
(Pankratov et al., 2002).  It is widely accepted that GABAA receptors undergo intracellular 
modulation via the activation of intracellular signalling cascades (Kittler and Moss, 2003) and 
we have focused on the impact of intracellular GABAA modulation on the interaction between 
the two receptors.  The introduction of phosphatase an kinase inhibitors Cylcosporine A, 
Staurosporine and KN93 to the extracellular solution revealed that Phosphatase II has no effect 
on the down regulation of GABA mediated currents mediated by activated P2X receptors on 
DRG neurons.  However, upon the blocking of PKA and CamKII the purinergic inhibition of 
GABAA receptors was eliminated.  Furthermore we later provided evidence for the role of PKC 
in this mechanism when the coapplication of Staurosporine and GF103209x successfully 
occluded the effect of P2X receptors on GABAA receptors on central neurons.  Observations 
have demonstrated that GABAA receptors possess a sequence of highly conserved 
phosphorylation sites on their β and γ subunits (Brandon et al., 2000; Vithlani et al., 2011).  As 
phosphoproteins GABAA receptors are targets of intracellular modulation via a Ca
2+
-dependent 
phosphorylation process (Brandon et al., 2002; Kittler et al., 2003; Kumar et al., 2005; Houston 
et al., 2009).  Our results confirm that the modulatory impact of P2X receptors on GABA 
receptors expressed on central neurons is governed by the calcium dependent activation of PKC.    
   Despite the strong evidence which suggests that the receptor communication between the 
two ionotrophic receptors is calcium dependent (Sokolova et al., 2001; Lalo et al., 2009) the 
underlying mechanism of this receptor interaction still remains controversial.  Another group 
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postulates that this receptor interaction occurs independently of calcium, but is a result of direct 
coupling of the intracellular components of the receptors via a QST motif located on the 
carboxyl terminus of the P2X receptor (Toulme et al., 2007).  However, the role of calcium is 
questioned after observations of the summation experiments also provide a possible role for 
direct coupling between the receptors.  When the functional linkage between the two receptors is 
removed via the application of PKC inhibitors and a high dose of calcium chelator the deficit in 
summation is not recovered, which would be expected if calcium was solely responsible for this 
receptor interaction (ref. Chapter 3, Fig. 3.3:13).  Therefore the results imply that P2X 
receptors ability to modulate GABA receptor mediated responses is dependent on Ca
2+ 
and 
phosphorylation, but to some extent may also involve direct coupling, marrying the two 
opposing paradigms of this receptor communication.  
 When making our observations of this receptor interaction in the central nervous system we 
used central neurons isolated from the somatosensory cortex.  The study of extracellular ATP on 
functional receptors expressed postsynaptically is relatively unexplored, specifically in native 
cells.  For cell lines it is typical to find an excessive density of receptors which can have adverse 
effects on neurotransmission, using native cells is beneficial as these effects are absent.  Also, in 
native cells the receptors are positioned in their “natural” arrangement and receptor composition.  
Therefore when pursuing the idea of looking at the effect of extracellular ATP on postsynaptic 
receptors in the central nervous system we utilized native cells acutely isolated from the brains of 
mice.    
 In our voltage clamp experiments on acutely isolated pyramidal neurons the GABAA 
receptors exhibited inhibition of their response recorded immediately after the application of the 
purinergic receptor agonists in 0.2 mM EGTA concentrations.  As previously observed in DRG 
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neurons this effect was not present under 10 mM EGTA concentrations, highlighting the role of 
calcium in this receptor mechanism.  Furthermore, the level of inhibition was to a marginally 
larger degree in central neurons than in DRG neurons.  Since our results support the theory that 
this interaction is predominantly calcium dependent the varying kinetically distinct P2X 
responses that we observe (both fast, slow and mixed responses) suggests the expression of a 
mixed population of P2X receptors on both DRG and central neurons which would give rise to 
different calcium permeability’s.  This observation coincides with the fact that one of the most 
predominant P2X receptor subtypes expressed on DRG neurons, P2X3, results in a rather limited 
calcium influx when activated (Virginio et al., 1998).  On central neurons P2X4 is the most 
predominant P2X receptor expressed and has a slower dessentisation rate than P2X3 and 
therefore a greater calcium influx, which would explain the higher degree of inhibition 
documented in central neurons compared to dorsal root ganglion neurons.   
 Not only do GABAA receptors respond to the local vesicular release of receptor agonist 
from the presynaptic terminal but another highly sensitive subclass of GABAA receptors can also 
respond to the low concentrations of GABA as a result of a spill over from the synaptic cleft, in a 
principal mechanism termed tonic inhibition.  Experimental observations suggest that this novel 
form of GABAA receptor signalling is also a target of purinergic modulation.  Additionally, the 
fact that we observed different phenotypic currents elicited from activated P2X receptors, 
suggests the possibility that the amount of calcium influx is variable depending on which P2X 
receptor subunits are expressed.  We have demonstrated the inhibition of GABA mediated 
currents by extracellular ATP in the peripheral and central nervous systems, which express 
different populations of purinergic receptor subtypes.   Furthermore, the occlusion of both phasic 
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and tonically activated GABAA receptors is indicative that this mechanism is not P2X receptor 
subunit specific and is a universal phenomenon.   
  The physiological implications of this regulatory pathway are yet to be fully 
investigated; however our results in brain slices reveal the potential of this innovative receptor 
interaction in the central nervous system (Lalo et al., 2009).  It has been established in recent 
years that purinoreceptors play a crucial role in synaptic plasticity, synaptic transmission and 
brain function.  Much of the spotlight of purinergic research is currently focused on its potential 
role in synaptic plasticity due to its important association with learning and memory, most of this 
work has been conducted in the hippocampus with little emphasis on the somatosensory cortex.     
However our data significantly suggests that astroglial derived ATP is a strong contributor to 
long term potentiation in the neocortex.  The extent of a purinergic role in inducing long term 
potentiation and other physiological processes is far from being fully understood, equally the 
underlying mechanisms to which also remain indeterminate.   
 The extracellular signalling properties of ATP provide the core foundations of inter- and 
intra-astroglial cell signalling in the central nervous system. The high permeability of P2X 
receptors to calcium is principal to their modulatory actions on the pre- and postsynaptic 
receptors at nerve terminals.  The integration of astroglial cells in to the synapse by enwrapping 
synapses to form the tripartite synapse, provides a source of functional support for neurons and 
consequently synaptic transmission.  Astrocytes are also able to transmit robust and regenerative 
calcium signals which target other astrocytes and neurons (Hassinger et al., 1996).   
Depolarisation of the presynaptic nerve terminal causes the release of neurotransmitters.  This in 
turn causes an increase in cytosolic calcium concentration within astrocytes, promoting the 
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generation of propagating calcium signals and the release of gliotransmitters, which propagate 
back to neuronal synapses to modulate synaptic transmission.   
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Figure 7:34.  A summary of the action of the purinergic receptors on GABAA receptors expressed 
on the postsynaptic membrane. 
ATP is co-released alongside GABA or alone in synaptic vesicles and diffuses across the synaptic cleft to 
activate postsynaptic P2X receptors.  The high permeability of P2X receptors to calcium is fundamental 
to actions of purinergic modulation in the central nervous system. Our studies demonstrate the down-
regulation of synaptic and extrasynaptic GABAA receptors in a calcium dependent manner, and also 
suggest the involvement of an intracellular signalling cascade.  Astrocytes also express P2X receptors, 
once activated there is an increase in the intracellular calcium concentration which stimulates the release 
of gliotransmitters such as ATP, glutamate and D-serine.  Glial cell derived ATP can also modulate 
postsynaptic GABAA receptors, representing a novel mechanism of GABA receptor regulation which 
could have important implications for GABA homeostasis and synaptic plasticity. 
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 Since astrocytes abundantly express P2X purinoreceptors and can release ATP as a 
gliotransmitter, this suggests the presence of a unique modulatory network involving neuron-
glial cell communications potentially of a purinergic origin.  At a functional level the precise role 
of astroglial cell derived P2X receptors is currently unknown, however previous studies and our 
data indicates that astroglial derived ATP induces long term potentiation in the central nervous 
system.  This is a relatively unexplored territory which requires more intense study, but 
essentially the paradigm of LTP induction by astroglial ATP extends the realms of the P2X 
receptors modulatory repertoire.   
 Once assumed to be just “brain glue” providing functional support to neurons, research into 
the role of astrocytes remained dormant for a long time.  However, recently researchers have 
devoted much effort in pursuing astrocytes, attempting to define their precise regulatory impact 
on synaptic transmission and brain function.  In their role as supporting cells, glial cells are 
responsible for the uptake of the residual neurotransmitter left in the synaptic cleft after release, 
such as glutamate and GABA as a method of maintaining the correct concentration of chemical 
transmitter at the synapse to prevent exocytotic cell death of neurons.  The study of the 
maintenance of GABA homeostasis by astrocytes in the central nervous system is a relatively 
unexplored topic which is currently under intense study.  P2X purinoreceptors embody a 
pioneering mechanism of GABAA receptor regulation.  Neuronal and astroglial cell derived ATP 
elevates the concentration of intracellular calcium concentration via stimulating P2X receptors, 
which in turn mediates the modulation of GABAA receptors in the peripheral and central nervous 
system.   
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